San Francisco-based Kadiant, a new startup focused on providing services to individuals diagnosed with autism spectrum disorder (ASD), has scored $300M in equity from private equity investor TPG Capital. According to TPG and Kadiant, Kadian...

Innovaccer, a developer of healthcare data sharing and digital health software, has raised $11M in a funding round, led by Microsoft's M12 venture capital investment arm. Innovaccer--based in India, but with its U.S. offices in San Francisc...

Sunnyvale-based PQ Bypass, a startup developing medical devices to treat Peripheral Arterial Disease (PAD), said last week that it has raised $60M in an equity funding round. The funding was led by Deerfield Management, and also included Se...

Palo Alto-based Mindstrong Health, which is developing technology it says can detect mental illness early to deliver preemptive care and improve outcomes, has raised $31M in an expanded Series B funding. The funding was led by General Catal...

South San Francisco-based Verily, the Alphabet spinoff working on life sciences technology, said Thursday afternoon that it has raised $1 billion in an investment round. The round was led by Silver Lake, and also included Ontario Teachersâ€...

Santa Rosa-based Millipede Medical, which makes transcatheter annuioplasty rings for treating mitral regurgitation, has been acquired by Boston Scientific, in a deal worth $325M, with a possible earnout of $125M more. Boston Scientific was ...

San Francisco-based Akero Therapeutics, a biotechnology startup developing treatments for non-alcohol steatohepatitis (NASH) and other serious metabolic diseases, said this week that it has raised $70M in a Series B funding round. The fundi...

Alameda-based Magnetic Insight, a developer of in vivo, deep tissue imaging technology, said on Wednesday that it has raised an $18M, Series A financing round. The funding was led by 5AM Ventures. The company also has raised funding from Sa...

Berkeley-based GenEdit, which develops polymer nanoparticle technology platform for non-viral-based delivery of gene therapeutics, said on Tuesday that it has raised $8.5M in a seed funding round. The funding was led by Data Collective Bio ...

Propeller Health, a developer of digital health products for patients with chronic obstructive pulmonary disease (COPD) and asthma, which has offices in San Francisco, has been acquired by ResMed, in a deal worth $225M. According to ResMed,...

Newark-based Intabio, a developer of biotherapeutics technology, announced on Tuesday that it had raised $9.5M in a Series A funding round. The funding was led by Northpond Ventures, and also included Genoa Ventures and Vertical Venture Par...

Redwood City-based Carrot, a developer of digital health software, announced on Monday that it has raised $25M in a funding round. The funding was led by Johnson & Johnson Innovation, and also included New York Life Ventures, Khosla Venture...

Emeryville, California-based Berkeley Lights, a developer of cell therapy technology, said today that it has raised $95M in a funding round. The funding was led by Nikon, and also included Sequoia Capital, Walden-Riverwood Ventures, Black...

South San Francisco-based CODA Biotherapeutics has raised $19M in a Series A funding, led by Versant Ventures and MPM Capital, with participation from Astellas Venture Management and Novartis, the company said this week. The new startup--in...

San Francisco-based Clarify Health Solutions said Monday that it has raised $57M in its Series B funding round. The funding was led by KKR, via KKR's Health Care Strategic Growth Fund. Clarify develops predictive analytics and machine learn...

South San Francisco-based Biodesy, a developer of technology for biomolecule characterization, announced on Monday that it has raised $20M in a Series C funding round. The funding was led by Alexandria Venture Investments, and also included...

San Francisco-based Cricket Health which is providing tech-enabled integrated kidney care services, has raised $24M in a Series A funding, the company said this week. The funding was led by Oak HC/FT. Other investors in the funding included...

San Jose-based Outset Medical, which develops technology aimed at reducing the cost and complexity of dialysis, has raised $132M in a Series D funding, the company said this week. The funding was led by Mubadala Investment Company, and also...

San Francisco-based RDMD, which is developing healthcare technology to accelerate drug development in rare diseases, has raised $3M in a seed funding round, the company said this morning. The funding was led by Lux Capital, and also include...

Redwood City-based Ambys Medicines, a biotechnology firm focused on people with serious liver disease, has raised $140M in funding, for its efforts to develop medicines for serious liver diseases. The company said the funding included $60M ...

San Francisco-based Verana Health, a developer of software which uses data from electronic health records to support development of new pharmaceuticals and devices, said on Tuesday that it has raised $30M in a Series C funding round. The fu...

South San Francisco-based Alector, a biotechnology company focused on finding treatments for neurodegenerative diseases and cancer, announced today that it has raised $133M in a Series E funding round. The funding came from Deerfield Manag...

Need help sleeping? Mountain View-based Beddr, a startup developing products which use a connected device and your smartphone to help you improve your sleep, has raised $5.6M in a Series A funding round, the company said this morning. The f...

Richmond, California-based Sangamo Therapeutics, which is developing gene therapy, genome editing, gene regulation, and other technology, has acquired French company TxCell, Sangamo announced onMonday. Sangamo will pay approximately $84M fo...

San Carlos-based personal genomics company Helix announced today that it has acquired HumanCode, a Denver-based company which was one of its partners. Financial details of the acquisition were not announced. As part of the acquisition, Heli...

San Mateo-based Vium, a developer of products which are aimed at helping allows pharmaceutical and biotechnology companies to conduct animal studies, has raised $24M in a Series B funding round. The funding came from Lux Capital and Data C...

San Francisco-based Eidos Therapeutics, a clinical stage biopharaceuticals firm focused on diseases caused by transthyretin (TTR) amyloidosis (ATTR), priced its IPO last night, saying it will sell 6,250,000 shares of its common stock at $17...

Palo Alto-based Mindstrong Health, a developer of technology which monitors brain health through measuring brain function based on a user's interaction with smartphones, has raised $15M in a Series B funding. The company said the new fundin...

San Jose-based Paradromics, a startup developing brain-machine interfaces that the company says can provide "high-volume bidirectional data streaming capabilities between brains and computers", has raised $7M in a seed funding, the company ...

San Francisco-based prenatal DNA screening startup Counsyl has been acquired by Salt Lake City, Utah-based Myriad Genetics, which develops molecular diagnostics and personalized medicine products, in a deal worth $375M. Myriad Gentics said ...

Menlo Park-based Grail, which is developing DNA-based, blood testing technology to detect cancer, has raised $300M more in funding, the company said this week. The funding came from Ally Bridge Group, Hillhouse Capital, 6 Dimensions Capital...

San Francisco-based Honor, which operates a home care company for older adults, has raised $50M in a Series C funding, the company said on Tuesday. The funding brings the company's total raised to $115M. The funding was led by Naspers Ventu...

San Francisco-based Thryve, a provider of personalized microbiotic and microbiome testing services, has raised $1.4M in a funding round, the company said this week. The funding came from PivotNorth Capital, Unilever Ventures, Darling Ventur...

Palo Alto-based Genoox has raised $6M in a funding round, the company said on Tuesday, for its genomic analysis software. The funding came from Triventures, and also included Inimiti Capital and Glilot Capital Partners. According to Genoox,...

San Mateo-based Notable, which is developing voice-powered personal assistants specifically for helping physicians with their health care, has raised $3M in a seed funding round, the company said this week. The funding was led by Greylock P...

Menlo Park-based Refuge Biotechnologies, which is developing cell therapies for oncology, said on Wednesday it has raised $25M in a Series B funding round. The funding was led by 3SBio and Sequoia China, and also included Danhua Capital (DH...

Santa Clara-based Agilent Technologies said on Wednesday afternoon that it has acquired Geneohm, a privately held company developing software for laboratory management. Financial details of the deal were not announced. Geneohm was based in ...

Mountain View-based biopharmaceuticals startup Attenua, which is developing medicines to treat chronic cough, has raised $35M in a Series A funding. The funding was led by Omega Funds, and also included Abingworth, OrbiMed and Redmile Group...

San Francisco-based Datavant, a developer of software used to "de-identify" personal information from healthcare data, in order to help improve medical research and care without compromising patient privacy or running afoul of HIPAA, has ra...

San Ramon-basd RubrYC Therapeutics, which says it is focused on using chemical libraries from HealthTell, Inc. to improve drug discovery throughput, has raised $10M in a Series A funding. The funding was led by Third Point Ventures, and als...

San Francisco-based Virta Health, a company developing what it says is a way to reverse type 2 diabetes and other chronic metabolic diseases, has raised $45M in a Series B funding. The funding came from Venrock, Obvious Ventures, Creandum, ...

Davis, California-based BioConsortia...

San Francisco-based synthetic DNA developer Twist Bioscience said this morning that it has raised another $50M in a private placement, bringing its total raised to $259M. Source of the new funding was not announced by the company. Twist sai...

San Francisco-based Atomwise, which is developing artificial intelligence software aimed at accelerating pharmaceuticals, biotech, and agrochemical research, said Wednesday that it has raised $45M in a Series A funding round. The funding ca...

Pleasanton, California- and Boulder, Colorado-based Inscripta has received $55.5M in a Series C funding, the company said this week, led by Merieux Developpement and Paladin Capital Group, and also included Venrock, Foresite, Spruce, and Na...

South San Francisco-based Senti Biosciences, a company developing gene- and cell-based therapies for challenging diseases, has raised $53M in a funding round, the company said on Tuesday. The funding was led by New Enterprise Associates, an...

Redwood Shores-based PROCEPT BioRobotics, a developer of surgical robots designed to treat benign prostatic hyperplasia (BPH), has raised $118M in an equity funding round, the company said on Wednesday. The funding was led by Viking GLobal ...

Fremont-based Intuity Medical has raised $42.5M, the company announced today, as the initial tranche of an ongoing $70M funding round for the maker of blood glucose monitoring devices. Intuity said the funding came from Accuitive Medical Ve...

Redwood City-based AEGEA Medical, a developer of devices for endometrial ablation, said this week that it has raised $40M in funding. $30M of the funding came from Perceptive Advisors, with an additional $10M raised from Alloy Ventures, Del...

Mountain View-based DNAnexus, a developer of biomedical information and data management software, said today that it has raised $58M in a financing round. The funding was led by Foresite Capital, and also included Microsoft, GV (formerly Go...

Menlo Park-based Drawbridge Health, a new startup focused on healthcare technology and personal diagnostic testing, has launched with the backing of GE Ventures. According to GE, Drawbridge Health is developing proprietary technology design...

Menlo Park-based Qool Therapeutics, which is developing non-invasive, temperature management systems aimed at treating clinical conditions in vascular surgery, cardiac arrest and trauma, has raised $8M in a Series A-1 funding round, the com...

San Mateo-based Medeor Therapeutics, a company which is developing cellular therapies for aid in organ transplants, starting with kidney transplants, has raised $57M in a Series B funding, according to the company. The funding was led by R...

San Francisco-based Denali Theaprutics, a biopharmaceuticals developer working on developing treatments for patients with neurodegenerative diseases like Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), has...

San Francisco-based Syapse, a developer of precision medicine products, said earlier this week that it has raised $30M in a Series D funding round. The funding came from Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation F...

Sunnyvale-based EBR Systems, a medical device developer which is developing wireleslly controlled, cardiac pacing systems used for treating heart failure, said yesterday that it has raised $50M in private equity funding. The funding came fr...

San Francisco-based Oyster Point Pharmaceuticals, a startup developing therapies for treating "dry eye" and other ocular diseases, said this week that it has raised $22M in a funding round. The funding was led by Versant Ventures and New En...

San Francisco-based Bloomlife, a developer of wearables aimed at fetal monitoring and preterm labor detection, has raised $2.3M in two grants, the company said today. The funding came from the Horizon 2020 Framework Programme of the Europea...

Menlo Park-based pharmacy delivery startup Nimble Pharmacy has added $28M in new funding, the company disclosed on Monday, in a round led by Sequoia Capital. The funding also included Y Combinator, First Round Capital, DAG Ventures and Khos...

Mountain View-based NeuroPace, a developer of neurostimulation systems to treat epilepsy, has raised $74M in a funding round. The funding was led by KCK Group and OrbiMed Advisors. The company is developing a brain-responsive neurostimulati...

Mountain View-based EchoPixel, a developer of 3D, interactive virtual reality software for the medical imaging market, has raised $8.5M in a Series A funding. The funding was led by Intel Capital, and also included Aurus Capital, Runa Capit...

Menlo Park-based Forty Seven, a developer of oncology drugs based on antibodies, has raised $75M in a Series B funding, the company said this week. The funding was led by Wellington Management Company, and also included Clarus Ventures, Lig...

Fremont-based Shockwave Medical, a developer of technology to treat calcified plaque that contributes to cardiovascular disease, has raised $35M in an extension of its Series C funding, the company said today. The funding came from Fidelity...

Emeryville-based Crystal Bioscience, the developer of chicken-derived, human antibody production technology, has been acquired by Ligand Pharmaceuticals. Ligand said it agreed to pay $25M in cash plus additional potential payments of up to ...

Haywards-based Paragon Genomics, a developer of next generation sequencing (NGS) technology, has raised $8M in a Series A funding. The funding was led by Cowin Venture Capital and Fosun Industrial Co., Limited, and also included Cloudstone ...

Mountain View-based 23andMe announced on Tuesday morning that it has raised $250M in a growth funding round. The round--which had been leaked last week--was led by Sequoia Capital, and also included Euclidean Capital, Altimeter Capital and ...

San Francisco-based Notable Labs, a provider of personalized medicine and cancer treatments aimed at treating brain cancer, has raised $10M in a Series A funding, the company disclosed last week. The funding was led by Builders VC, and also...

Emeryville-based Gritstone Oncology, a cancer immunotherapy startup focused on personalized medicine for treating patients with non-small cell lung cancer and gastric cancer, said last week that it raised $92.7M in a Series B funding round....

San Francisco-based genomics testing startup 23andMe has raised $200M in a new funding round, according to multiple sources, in a round that values the company at around $1.5 billion. The funding was led by Sequoia Capital....

Redwood City-based ARMO Biosciences, a developer of cancer treatments, said today that it has raised $67 in a Series C-1 funding. The funding was led by Qiming Venture Partners, and also included Decheng Capital, Sequoia Capital, Quan Capit...

South San Francisco-based Freenome said today that it has raised $7M more in its Series A funding, bringing its total raised for its disease screening company to $72M. the funding was led by Section 32, the venture firm led by former GV CE...

Foster City-based MedGenome, a developer of cancer immunotherapy biomarkers and other genomics research and diagnostics products, said today that it has raised $30M in a Series C funding. The funding was led by Sequoia India and Sofina s.a....

San Francisco-based UNITY Biotechnology, which is developing biopharmaceuticals aimed at preventing, halting or reversing diseases of aging, has raised $35M in additional Series B funding, the company said last week. The new funding came fr...

Redwood City-based Atreca, a developer of cancer treatments, announced this morning that it has raised $35M in a Series B funding. The funding was co-led by Wellington Management Company and an un-named healthcare focused fund, along with ...

San Francisco-based Phil, a prescription management and delivery service for local pharmacies, has raised $10M in a Series A funding, the company said this morning. The funding was led by Crosslink Capital, and also included Eniac Ventures,...

San Francisco-based Flo, the maker of a smartphone app which lets women track their ovulation cycle, has raised $5M in a Series A funding. The funding was led by Flint Capital, and also included supermodel Natalia Vodianova, along with othe...

San Francisco-based Modern Fertility, a provider of fertility testing services for women, has raised $1M in a funding round, the company disclosed this week. The funding came from First Round Capital, Box Group, and Y Combinator. The compan...

Redwood City-based Karius, a developer of DNA-based infectious disease testing technology, announced on Monday that it has raised $50M in a Series A funding round. The funding was led by Data Collective and Lightspeed Venture Partners, and ...

South San Francisco-based Meissa Vaccines, biotech startup developing vaccines to prevent viral, respiratory infections, has raised a seed funding, the company said last week. Size of the funding was not announced. The funding came from Fun...

San Carlos-based Auris Robotics, a surgical robot developer, disclosed this week that it has raised $280M in a Series D funding. The funding was led by Coatue Management, and also included Mithril, Lux Capital, and Highland Capital Partners...

Cupertino-based VIOME, a startup which says it is using artificial intelligence combined with at-home, health testing, to provide people with insights into their personal health, has raised $15M in a Series A funding, the company said today...

South San Francisco-based Kezar Life Sciences said last week that it has raised $50M in a Series B funding. The funding was led by Cormorant Asset Management and Morningside Venture, and also included Cowen Healthcare Investments, Pappas Ve...

San Francisco-based Hinge Health, a developer of digital care software aimed at treating musculoskeletal disorders, has raised $8M in a Series A funding, the company disclosed this morning. The funding was led by Atomico, and also included ...

Cirtec Medical, a provider of outsourced medical device design, engineering and manufacturing which has a facility in Los Gatos, has raised $136M in a funding round. The funding came from 3i Group plc. Cirtec Medical is based in Brooklyn Pa...

Pleasanton-based Unchained Labs, a developer of tools used in the life sciences industry, said today that it has acquired Trinean, a developer of systems that measure protein, DNA and RNA concentration in biologics and genomics samples. Fin...

Palo Alto-based Mindstrong Health, a company which is using artificial intelligence and mobile apps to help diagnose neuropsychiatric disorders, has raised $14M in new funding, the company said last week. The funding was led by Foresite Cap...

San Francisco-based DNA synthesis startup Twist Bioscience announced this morning that it has added $27M more in new funding, on top of the $33M it raised in March, bringing its total funding round to $60M. The company said the new funding ...

San Francisco-based Invitae, a provider of genetic testing services, says it has acquired Ommdom Inc., the operator of CancerGene Connect, an online software platform which helps collect and manage family genetic history. Invitae said it pa...

San Francisco-based ScriptDash Pharmacy, which operates an online, prescription pharmacy service has raised $23M in a funding round, rebranded itself to Alto Pharmacy, and expanded to Los Angeles. The funding round came from Greenoaks Capi...

South San Francisco-based biotech startup Harpoon Therapeutics, which is developing T-cell recruiting biologic therapies for the treatment of cancer, has raised $45M in a Series B funding round. The funding was led by Arix Bioscience and Ne...

San Francisco-based Viz, a developer of artificial intelligence software to help in emergency treatment of stroke, has raised $7.5M in a seed funding. The funding was led by DHVC (Danhua Capital) and Eric Schmidt's Innovation Endeavors and ...

San Francisco-based Lemonaid Health, which provides prescription delivery of such sensitive prescriptions as birth control bills, urinary tract infection (UTI), acne, hair loss, and other conditions, has raised $12M in a Series A funding, t...

San Francisco-based Conversa, a developer of communications tools to help improve the flow of information between doctors and patients, has raised $8M in a Series A funding round. The funding was led by Northwell Ventures, and also included...

Redwood City-based Guardant Health, a cancer diagnostics and testing provider, said this week that it has raised $360M in funding. The funding was led by SoftBank, and also included Sequoia Capital, Khosla Ventures, Lightspeed Venture Partn...

San Jose-based Outset Medical, a developer of hemodialysis products, said last week that it has raised $76.5M in a Series C funding round. The funding came from T. Rowe Price Associates, and also included Fidelity Management & Research Com...

Santa Clara-based Advanced Cardiac Therapeutics (ACT), a medical device company which is developing an ablation catheter to treat cardiac arrhythmias including atrial fibrillation, said on Tuesday that it has raised $45M in an equity fundin...

San Francisco-based ReThink Medical, which is developing software which uses information from medical devices to prevent hospitalization for heart failure patients, has raised $3M in a Series A funding. The funding came from Emergent Medica...

San Mateo-based Evidation Health, a company that is working on quantifying patient outcomes healthcare ventures, has raised $10M in a funding round, the company said today. The funding was led by Sanofi-Genzyme BioVentures, and also include...

South San Francisco-based Circle Pharma, which is developing a computational and synthetic chemistry platform aimed at enabling macrocyclic peptide therapeutics, has upped its Series A funding to a total of $6.5M. The company said the new f...

Santa Cruz-based Two Pore Guys (2PG), a developer of handheld, molecular diagnostics technology, has raised $24.5M in a Series A funding, the company announced on Tuesday. The funding as led by Khosla Ventures. The company's diagnostics pla...

Mountain View-based electronic health records and medical billing software developer Drchrono has raised $12M in a Series A funding round, the company disclosed this week. The funding came from Runa Capital and Maxfield Capital, and also in...

San Francisco-based Amino, which maintains a database of medical claims and medical bills, which it uses to help provide better cost estimates for health procedures to employers, doctors, and hospitals, has raised $25M in a Series C funding...

South San Francisco-based Antiva Biosciences, a biopharmaceuticals startup targeting treatments for pre-cancerous lesions caused by human papilloma virus (HPV) infection, said it has raised $22M in a Series C funding. The funding was led by...

Palo Alto-based Cognoa, a developer of machine-learning-based technology use to diagnose and track early signs of autism in children with developmental delays, has raise $11.6M in a funding round, the company said this morning. The funding ...

San Francisco-based DNA manufacturing technology startup Twist Bioscience announced this morning that it has raised another $33M in funding, bringing its total raised to $166M. Source of the new funding was not announced. The company said i...

San Ramon-based BioClin Therapeutics, a drug development company focused on treating metastatic cancer, has raised $30M in a Series B funding, the company announced this morning. The funding was led by Sofinnova Ventures and Ysios Capital, ...

Foster City-based SutroVax, a company developing pneumococcal conjugate vaccines, announced on Tuesday that it has raised $60M in a Series B funding round. The funding was led by Frazier Healthcare Partners and Pivotal bioVenture Partners, ...

Hayward-based Moximed, a developer of implants used to treat patients with knee osteoarthritis (OA), has raised $50M in a Series F funding, the company said this week. The funding came from Advent Life Sciences and Future Fund, along with N...

South San Francisco-based FDB (First Databank, Inc.), said on Thursday that it has acquired Morrisville, North Carolina-based Polyglot Systems. Financial terms of the acquisition were not announced. FDB is a provider of drug and medical dev...

Mountain View-based digital health startup Livongo Health has raise $52.5M more in an investment, the company said on Thursday, to help it with growth efforts and international expansion. The company said the new funding was co-led by Gene...

Mountain View-based AliveCor, a developer of mobile EKG technology which lets doctors monitor their patients for heart issues remotely, has raised $30M in a new funding round. The funding came from Omron Healthcare and Mayo Clinic, along wi...

San Francisco-based Virta Health, a startup which operates specialty health clinics to reverse type 2 diabetes, has raised $37M in a funding, the company announced today. The funding came from Venrock, Allen & Company, Ev Williams' Obvious ...

Menlo Park-based GRAIL, announced this morning that it has raised $900M in a first close of a planned, $1 billion funding round. The Series B funding was led by Arch Venture Partners, and included Johnson and Johnson Innovation, Amazon, Bri...

San Francisco-based Xcell Biosciences announced that it has raised $12M in a Series A funding round, the company said this morning. The funding was led by HBM Genomics, and also included its other major existing investors. HBM Managing Dire...

San Francisco-based Sensely, a developer of "virtual" medical assistant software, which helps physicians monitor a patient's health, has raised $8M in a Series B funding round. The company's virtual, on-screen assistants run on mobile phone...

Pleasanton-baed ZELTIQ Aesthetics, a developer of body contouring products for the aesthetic medicine market, has been acquired by Allergan plc, in a deal worth $2.47 billion in cash, the two said this morning. ZELTIQ, which is traded on th...

San Francisco-based Nuna , a developer of a data platform to collect Medicaid data, said last week that it has raised $90M in funding. The funding came from Kleiner Perkins Caufield & Byers and John Doerr. The company says that it is lookin...

Oakland-based Omicia has acquired Seattle-based Spiral Genetics, a developer of software for the next generation DNA sequencing market. Financial details of the acquisition were not announced by the companies. Omicia said the buy will help ...

San Francisco-based Adynxx, a developer of therapeutics for treating chronic pain, said this week that it has raised $16M in a Series B funding round. The funding was led by TPG Biotech, and also included Domain Associates. TPG's Heath Luka...

Livermore-based POC Medical Systems, a developer of a portable, breast cancer screening test, has raised $21M in a Series A financing. The funding was led by BioVentures Investors and also included Sirius America Insurance Company, IFG Heal...

San Francisco-based biopharmaceuticals developer CiVi Biopharma, a biopharmaceuticals firm which is targeting cardiometabolic diseases, has raised $40M in a funding round, the company said on Friday. The investment came from Boxer Capital o...

San Francisco- and Bozeman, Montana-based SiteOne Therapeutics said on Friday that it has raised $15M in a Series B investment round. The funding was led by Amgen, and also included Next Frontier and other investors. SiteOne is developing n...

San Francisco-based Vir Biotechnology, a new startup which says it is developing cures, treatments, and preventions for challenging infectious diseases, said today that it has raised $150M in funding, and launched the startup. The company i...

Menlo Park-based GRAIL, a startup that is developing blood testing technology for early stage cancer detection, is expecting to close a $1 billion, Series B funding, according to founding investor Illumina. Grail, which raised $100 million ...

Redwood City-based Synthego, which develops a synthetic RNA designed for genome engineering, has raised $41M in a Series B funding round. The funding was led by 8VC, and also included AME Cloud Ventures, Elements Capital, OS Fund, Alexandri...

Redwood City-based Revolution Medicines, a biopharmaceuticals firm aiming to treat cancer by attacking frontier oncology targets, proteins which drive the growth of cancer, has raised $25M in a Series A extension financing. The funding came...

Walnut Creek-based Providence Medical Technology, which develops cervical fusion technology, said Monday that it has raised $10.5M in equity funding. The funding was led by MVM Life Science Partners, and also included Stanmore Medical Inve...

Menlo Park-based Clear Labs, which is using DNA sequencing technology for the molecular analysis of food, has raised $13M in a Series B funding round, the company announced this morning. The funding was led by Wing VC, and also included Goo...

San Francisco-based Augmedix, a startup which is using Google Glass to shortcut the amount of time physicians have to spend on documentation for electronic health records (EHR) systems, has raised $23M in a stragic funding, the company anno...

Fremont-based Shockwave Medical, which is developing treatments for calcified cardiovascular disease, has raised $45M in a Series C funding round. The funding was led by Sectoral Asset Management, and also included T. Rowe Price Associates,...

Campbell, California-based Apama Medical, a medical device developer developing a catheter ablation system for the underpenetrated atrial fibrillation (AF) market, has raised $13M in a Series C funding. The funding came from Ascension Ventu...

Sunnyvale-based Intuity Medical, a developer of a blood glucose meter called the POGO, has raised $40M in a Series 3 funding, the company announced on Thursday. The funding was led by PTV Healthcare Capital, along with Luther King Capital M...

San Francisco-based PlushCare, which is providing online "urgent care" services for patients, has raised $8M in a Series A funding round. The funding was led by GGV Capital, and also included Lightspeed Venture Partners and Exponent. Jeff R...

San Francisco-based uBiome, a developer of a service which uses DNA sequencing to test for the microbiome in the human gut, has raised $22M in a Series B funding, the company disclosed today. The funding was led by 8VC, and also included Sl...

San Francisco-based Benchling, a developer of life sciences R&D software, said Monday that it has raised $7M in a new funding round. The funding was led by Thrive Capital, and also included Andreessen Horowitz, Geoff Ralston (Y Combinator),...

Menlo Park-based biotech investor Sofinnova says it has raised $650M in its newest fund, Sofinnova Venture Partners X. According to the firm, it closed the fund at its "hard cap" of $650M, after exceeding its initial funding target of $550M...

Emeryville-based Zymergen, a startup that is tying together data science, automation, and biology for the chemical and materials, agriculture, and healthcare market, has raised $130M in a Series B funding. The funding was led by SoftBank Gr...

San Francisco-based iRhythm, which develops cardiac monitoring systems, said in a filing on Friday that it expects it IPO to price at between $13.00 and $15.00 per share. The company is selling 5,350,000 shares of its common stock in its of...

Hayward-based MicuRx Pharmaceuticals, which is developing oral and intravenous antibiotics to treat MRSA, has raised $55M in a Series C funding, the company announced this morning. The funding was led by GP Healthcare Capital, and also incl...

San Francisco-based Tobira therapeutics, a publicly held biopharmaceuticals firm developing threapy to treat liver disease, has been acquired by Allergan, in a deal worth $1.695 billion. Allergan said it will pay $28.35 per share in cash, a...

San Francisco-based IDbyDNA, a developer of technology that uses DNA to identify pathogens and infectious disease, has raised $9M in a Series A funding, the company said this morning. The funding was led by ARTIS Ventures, and also included...

Palo Alto-based Inscopix, which develops brain mapping technology, said this week that it has pulled in $10M in a Series A funding round. The funding was led by Playground Ventures, and also included AME Cloud Ventures and Floodgate Fund. T...

Mountain View-based Apple has acquired personal health data and electronics medical records startup Gliimpse, according to a report today. Fast Company said that Apple acquired the company earlier in the year. Gliimpse was founded by Anil S...

Milpitas-based biopharamceuticals developer Protagonist Therapeutics, which is developing peptide-based biopharmaceuticals, has raised $90M in its IPO, selling 7,500,000 shares of its common stock at $12.00 per share. The company is now tra...

South San Francisco-based Iconic Therapeutics, which is targeting treatments for retinal disease and cancer, said on Tuesday that it has added $10M in funding to its existing, Series C funding round. The new funding came from Xeraya Capital...

Burlingame-based Cleave Biosciences, a developer of protein-based technology for treating cancer, has raised $37M in a Series B funding round. The funding came from Celgene, Nextech Invest Ltd. and Arcus Ventures, plus 5AM Ventures, Clarus ...

San Francisco-based Honor, a startup which helps families find home care for older adults, has raised $42M in a Series B funding round, the company said this morning. The funding was led by Thrive Capital, and also included 8VC, Andreessen ...

San Francisco- and Brentwood, Tennessee-based MDsave, an online healthcare marketplace which offers up pre-negotiated rates on medical care, has received a strategic investment from Cambia Health Solutions, the two said this morning. Size o...

San Francisco-based Audentes Therapeutics has priced its IPO, saying late Tuesday evening that it will offer 5,000,000 shares of its common stock at $15.00 per share. The company priced at the midpoint of its earlier, estimate IPO range of ...

Foster City-based SciClone Pharmaceuticals said this morning that it has decided to remain an independent, publicly traded company, and is no longer talking to potential acquirers. The company--which is traded on the NASDAQ as SCLN--had lau...

San Francisco-based Trace Genomics is looking to bring the world of DNA testing to agriculture, saying today that it has launched a new service to test the microbiome of soils, to help farmers figure out what diseases might affect their cro...

San Francisco-based gene therapy developer Audentes Therapeutics has set the IPO pricing range for its upcoming IPO, saying in a filing this morning that it is hoping to sell 5,000,000 shares of its common stock at between $14.00 and $16.00...

South San Francisco-based Annexon Biosciences, a biopharmaceuticals firm focused on treatments for neurodegenerative disorders, says it has raised $44M in a Series B funding. The funding was led by New Enterprise Associates, and also includ...

Morgan Hill-based Paramit, a provider of outsourced medical device and life sciences equipment manufacturing services, said today that it has acquired San Jose-based Lathrop Engineering. Financial terms of the buy were not disclosed. Lathro...

San Jose-based VitalConnect, a developer of medical biosensors, says it has raised $25M in a financing round, from a combination of $7.8M in a Series B equity funding, and a $17.5M term loan. The term loan came from Perceptive Advisors LLC,...

Milpitas-based Applied StemCell, which is developing gene editing technology and tools based on stem cell technology, has raised $19M in a Series D funding round. The company said earlier this week that the Series D investment was led by He...

Oakland-based Omicia, which is developing clinical genome interpretation and reporting software for the personalized medicine market, said this morning that it has raised $23M in a Series B funding. The funding came from UPMC Enterprises, R...

Mountain View-based Alexza Pharmaceuticals said earlier this week that it is being acquired by Spanish company Grupo Ferrer Internacional, in a deal worth approximately $11.4M. Ferrer said it will pay $0.90 per share in cash for Alexza Phar...

San Francisco-based MIODx, a company working on biomarker diagnostics, announced Friday morning that it has raised $1.5M in a seed funding round. Source of the funding was not announced. The company said the funding will go towards its clin...

San Francisco-based MIODx, a company working on biomarker diagnostics, announced Friday morning that it has raised $1.5M in a seed funding round. Source of the funding was not announced. The company said the funding will go towards its clin...

San Francisco-based venture capital ivnestor venBio announced this morning that it has raised $315M in its second life sciences fund, venBio Global Strategic Fund II. The funding came from Amgen, Merck, and Baxalta, along with a number of o...

San Francisco-based Stemcentrx, a biopharmaceuticals developer focused on cancer, has been acquired by AbbVie in a $5.8 billion deal, the two said this morning. AbbVie said it would pay $2.0 billion in cash, and the remainder in stock for S...

Redwood City-based Naya, a startup developing "smart" breast pumps for mothers, has raised $3.9M in seed funding, according to the company. Naya develops smartphone connected, hydraulic breast pumps which it sells for $599. The funding came...

San Francisco- and Shanghai-based Hua Medicine, a developer of treatments for diabetes, says it has raised $50M in a Series C financing. The funding was led by Harvest Investments, and also included Frontline BioVentures, ARCH, Venrock, Fid...

Mountain View-based Livongo Health, which develops software to help manage diabetes, has raised $44.5M in a Series C funding. The funding came from Merck Global Health Innovation Fund, Cowen Private Investments, Sapphire Ventures, Zaffre In...

San Francisco-based Zipline, a developer of medical delivery drones aimed at delivering life saving medicines to the third world, has scored funding for its efforts, from Sequoia Capital, GV, SV Angel, Jerry Yang, Paul Allen, and Stanford U...

South San Francisco-based molecular diagnostics developer Veracyte said earlier this week that it has raised $45M in financing, from Visium Healthcare Partners LP. Publicly held Veracyte said the financing comes in a com bination of a term ...

Sunnyvale- and Austin-based Aerin Medical, a developer of non-invasive, medical d‪evies designed to treat nasal breathing disorders, has raised $16.7M in a Series C funding, the company announced this morning. The funding included $6....

Menlo Park-based medical device startup Sight Sciences hsa raised $7M in a Series B funding, the company said this week. The funding was led by Hicks Equity Partners, and also included Scientific Health Development, Allegro Investment Fund,...

San Carlos-based Alvine Pharmaceuticals, which is developing treatments for celiac disease, has been acquired by ImmunogenX, the two said late Tuesday. Financial terms of the acquisition were not disclosed. ImmunogenX is a developer of biop...

San Mateo-based Optimus Outcome, a provider of services and technology around managing autism, has acquired San Francisco-based Autism Acumen, a developer of video-based tools for managing chronic neurological disorders. Financial terms of ...

Menlo Park-based Spirox, which is developing medical devices for treating nasal obstruction, has raised $45M in a Series C funding. The funding was led by KKR, and also included HealthQuest Capital, Aisling Capital, Aperture Venture Partner...

Menlo Park-based healthcare investor HealthQuest Capital said today that it has raised $225M in a new fund, HealthQuest Capital II, LP, well past its initial target of $175M. The investor said the funds came from un-named endowments, family...

San Ramon-based HealthTell, which is developing diagnostic tests for autoimmune diseases like lupus, has raised $26M in a Series B funding, the company announced this morning. The funding was led by Third Point Ventures, and also included P...

San Francisco-based medical imaging software developer Arterys said this morning that it has raised $12M in a Series A funding round. The funding came from Emergent Medical Partners, GE Ventures, the Stanford-StartX Fund, and Norwich Ventur...

South San Francisco-based Tizona Therapeutics said this morning that it has raised $43M in a Series B funding round. The funding came from Abingworth and Canaan Partners along with Lightstone Ventures, MPM Capital, Amgen Ventures, Astellas ...

San Jose-based InCube Labs, a medical device and drug delivery R&D organization, has spun out Fe3 Medical, a new company developing transdermal patches to treat iron-deficiency anemia. Fe3 Medical said it raised $11M in a funding round from...

Palo Alto-based Forty Seven Inc., which is developing antibodies aimed at attacking cancer tumors, has raised the first half of a $75M in a Series A financing, the company said today. The company said the Series A was led by Lightspeed Vent...

Redwood City-based Pliant Therapeutics, a new company focused on treatments for fibrotic diseases of the lungs, has raised $45M in a Series A funding. The funding came from Third Rock Ventures. Plaint has named Bernard Coulie, M.D., Ph.D. a...

San Francisco-based Lantern, a startup developing online, mental health wellness services, said this week that it has raised $17M in an investment round. The round came from healthcare company UPMC, and also included Mayfield Fund, SoftTec...

Redwood City-based ARMO BioSciences, which is developing immunotherapy drugs, announced today that it has raised $50M in a Series C financing. The financing came from Kleiner Perkins Caufield & Byers (KPCB), OrbiMed, DAG Ventures and NanoDi...

San Francisco-based One Medical Group, a provider of technology-enabled healthcare services, said Friday that it has acquired San Francisco-based Rise, a developer of a health coaching platform. Financial terms of the buy were not announced...

South San Francisco-based EpiBiome, which says it is developing an alternative to small molecule antibiotics for agriculture, has raised $6M in a Series A funding round today. The funding came from Viking Global Investors via the Illumina A...

Mountain View-based Jan Medical, a developer of non-invasive, brain diagnostics tools used to diagnose concussions and stroke, said today that it has raised $7.5M in a Series C funding. The funding came from Brainlab, Inc. The company said ...

Redwood City-based Guardant Health, which is developing cell-free, DNA liquid biopsy technology for cancer testing via blood samples, said today that it has raised $100M in a Series D funding. The funding was led by OrbiMed Advisors, and al...

San Francisco-based Alector, a developer of immuno-modulatory therapies for Alzheimer's disease and other neurodegenerative disorders, announced today that it has raised $29.5M in a Series D financing. The funding was led by Dementia Discov...

Palo Alto-based Quartzy, a developer of software for managing research, biotech, and pharmaceuticals labs, has raised $17M in a funding round, the company disclosed today. The Series B funding came from Emergence Capital, along with Khosla ...

Palo Alto-based OMT (Open Monoclonal Technology), a developer of genetic engineering technology to allow animals to create human, therapeutic antibodies, has been acquired by Ligand in a $178M deal. Ligand said it will pay $92.6M in cash an...

San Francisco-based One Medical Group, the operator of a network of technology-enabled, primary care medical services locations, said this week that it has raised $65M in a growth capital funding. The funding came from J.P. Morgan Asset Man...

Mountain View-based Eargo, a developer of high tech, in-ear hearing aids, has raised $25M in a Series B, the company announced today. The funding was led by New Enterprise Associates. The company said the funding goes to scale business oper...

San Francisco-based Lively, a developer of platforms to help monitor the safety of older family members, has been acquired by GreatCall, the companies said last week. Financial terms of the asset acquisition were not announced. Lively was f...

South San Francisco-based biotherapeutics developer True North Therapeutics announced this morning that it has raised $40M in a Series C funding. The funding came from Newaf Venture Partners, along with Perceptive Advisors, Cowen Private In...

South San Francisco-based ORIC Pharmaceuticals said today that it has raised $53M in a Series B funding. The company, which is developing small molecule drugs to treat cancer, said the funds came from The Column Group, Topspin Partners, Orb...

San Francisco-based Symic, a biopharmaecuticals company which is developing multiple compounds related to the extracellular matrix (ECM), has raised $25M in a Series A-2 financing. The funding was led by Lilly Ventures, and also included th...

San Mateo-based HealthCrowd, a developer of mobile messaging apps for healthcare providers and health plans, has raised $2.1M in seed funding, according to the company. The funding came from Startup Capital Ventures, Herlitz Capital, Healt...

San Francisco-based PresenceLearning, a provider of live, online speech therapy, occupational therapy, and behavior and mental health services for K-12 students, said Thursday that it has raised $25M in a Series C funding. The funding was l...

San Francisco-based Joyable, a developer of mobile apps to help people overcome social anxiety, said earlier this week that it has raised $8M in a Series A funding. The funding was led by Thrive Capital and Harrison Metal, the company's see...

Redwood City-based Athos, a developer of wearable fitness technology, said Wednesday that it has raised $35.5M in a Series C funding round. The funding was led by Social Capital, and also included MAS Holdings, Lightspeed Venture Partners...

San Francisco-based Verge Genomics, which is using genomics data to accelerate development of drugs to treat neurodegenerative disease, has raised $4M in a seed funding, the company said Tuesday. The funding was led by IA Ventures, and also...

Menlo Park-based lifesciences investor Frazier Healthcare Partners announced a new, $262M life sciences fund this morning, Frazier Life Sciences VIII, L.P.. The fund closed with $262M in capital commitments, which it says it will invest exc...

Sunnyvale-based Silk Road Medical, a developer of surgical technology to treat stroke, has raised $57M in a combination of equity and debt. The debt funding was led by CRG. The equity came from CRG, Warburg Pincus, and The Vertical Group. ...

San Francisco-based Gritstone Oncology, a biopharmaceuticals firm developing cancer immunotherapies, has raised $102M in a Series A financing, the company said today. The funding came from Versant Ventures, The Column Group, Clarus Ventures...

Richmond, California-based Naia Limited, which is developing treatments for short bowel syndrome (SBS), non-alcoholic steatohepatitis (NASH) and Type 2 diabetes, said this morning that it has raised $5.3M in a Series A financing round. The...

Mountain View-based genetics analysis developer 23andMe says this morning that it has raised a big, $115M Series E funding round, led by Fidelity Management & Research Company. The funding also included Casdin Capital, WuXi Healthcare Ventu...

South San Francisco-based MiNDERA, a startup that it developing a non-invasive, molecular diagnostics test for dermatology and skin-related cancers, has raised $1M in a seed funding round. The funding came from Scientific Health Development...

Berkeley-based Adheron Therapeutics has been acquired by Roche, in a deal worth $105M in an upfront payment, plus earnout worth up to an additional $475M. Adheron Therapeutics develops technology that disrupts immune cell adhesion, which is...

South San Francisco-based Cytomx had its IPO debut this morning, pricing last night at $12.00 per share, and rising as high as $17.02 this morning immediately after its IPO. The developer of cancer therapeutics was venture backed by Third R...

San Jose-based Peaxy, a developer of data analytics and access tools for the engineering and life sciences area, said today that it has raised $15M in a Series B funding. The company said the funding came from angels, including Federico Fag...

San Francisco-based Clover Health, a health insurance company which uses software technology to help reduce healthcare costs, has raised $100M in a combined equity and debt funding. The funding came from First Round Capital, and also includ...

San Francisco-based biotech Alector has raised $32M in a Series C funding, to help fund its treatments for Alzheimer's disease and other neurodegenerative disorders, the company said Wednesday. The funding came from MRL Ventures, and also i...

San Francisco-based digital health product developer Omada Health has raised $8M in a Series C funding, the company announced this morning. The funding was led by Norwest Venture Partners, and also included Humana, Providence Health & Servi...

Menlo Park-based ClearLabs, which is developing a genomics-based food quality testing equipment, said today that it has raised $6.5M in a Series A funding. The funding came from Khosla Ventures, Felicis Ventures, and un-named strategic inve...

Menlo Park-based Medina Medical, a medical device company looking to train cerebral aneurysms and other brain injury, has been acquired by Medtronic plc. Medtronic said it would pay $150M plus additional payments based on key milestones. Me...

Sunnyvale-based DynoSense, a developer of remote, health monitoring and scanning technology, has raised $9.4M in a Series A funding, according to the company. The funding came from WI Harper Group, JKOM Cloud Health Technology Co., Plug and...

San Francisco-based Grand Rounds, an online platform for connecting health care providers and patients, said Thursday that it has raised $55M in a Series C funding round. The funding came from Greylock, Venrock, Harrison Metal, and David Eb...

San Mateo-based PokitDok, which develops a cloud-based product to help streamline healthcare business transactions, has raised $34M in a Series B funding. The company's backers include New Atlantic Ventures, Rogers Venture Partners and Subt...

Pleasanton-based Virtual Incision, which is developing robotically assisted surgical devices, has raised $11.2M in a funding round. The funding was led by Bluestem Capital, and also included PrarieGold Venture Partners and the company's oth...

Menlo Park-based Antiva Biosciences, a biopharmaceuticals company developing antiviral drugs to treat Human Papillomavirus infections, said today that it has raised $16M in a Series B funding. The funding came from Canaan Partners and Sofin...

San Francisco- and Bangalore-based MedGenome, which provides genomics diagnostic testing and research services, said today that it has raised $20M in a Series B funding round. The funding came from Sequoia Capital, along with prior investor...

Milpitas-based Protagonist Therapeutics, which is developing biotherapeutics aimed at treating inflammatory bowel disease, has raised $40M in a Series C funding. The funding was led by Canaan Partners, and also included Adage Capital Manage...

Redwood Shores-based PROCEPT BioRobotics, which develops medical devices which use waterjets to remove tissue to treat lower urinary tract issues, has raised $42M in a funding round. The funding was led by Novo A/S, and also included CPMG a...

South San Francisco-based Oculeve, a medical device company developing treatments for dry eye disease, has been acquired by Dublin, California-based Allergan, the two said this morning. The two said Allergan will pay $125M in an upfront pay...

San Francisco-based Sense.ly, which is looking to apply artificial intelligence to help engage with patients and better monitor chronic diseases, said today that it has raised $2.2M in a Series A funding. The funding came from Launchpad Dig...

South San Francisco- and Cambridge, Mass.-based healthcare venture investor Clarus Ventures said today that it has closed on a $500M fund, its third, Clarus Lifesciences III, L.P.. Clarus said the new fund brings its total under management ...

San Francisco-based Twist Bioscience said this morning that it has raised $37M in a Series C financing round, led by Illumina. The funding also included Fidelity Management and Research Company and Foresite Capital Management , Nick and Job...

San Francisco-based Metabiota>, which develops software used to predict disease hot spots and outbreaks, has raised $30M in a series A funding, the company said THursday. The funding comes from RSTP, Capricorn Health & Special Opportunities...

Pleasanton-based Diagnostic BioSystems, which develops kits used for immunohistochemistry, said this week that it has received a round of growth capital from BroadOak Capital Partners. Size and terms of that funding were not announced. The ...

Redwood City-based AEGEA Medical, a developer of medical devices used to treat abnormal uterine bleeding, has raised $36M in a Series C funding. The company said today that the funding came from Alloy Ventures, Delphi Ventures, and Covidien...

NeuroVigil, a developer of brain monitoring technology said late Friday evening that it has raised a second financing round. Size of the funding round was not disclosed. The funding came from Howard Morgan, Elon Musk,Tim Draper, Draper Fish...

South San Francisco-based MyoKardia, which is developing treatments for genetics-related heart disease, said yesterday that it has raised $46M in a Series B funding. The funding came from an un-named public investment fund, Casdin Capital, ...

San Francisco-based InCarda Therapeutics said Tuesday that it has raised $5M in a Series A funding, to go towards its therapies for acute cardiovascular conditions. The funding came from Morningside Ventures and angels. The company is devel...

Palo Alto-based Carmenta Bioscience, which is developing diagnostics tools to detect preclampsia, has been acquired by Progenity, a molecular and specialized diagnostic testing services. Financial terms of the acquisition were not disclosed...

Mountain View-based Scanadu, one of the startup developing handheld, medical vital signs gadgets for the Qualcomm Tricorder XPRIZE, said today that it has raised $35M in a funding round for its technology. The company said the Series B fun...

San Francisco-based Quanticel Pharmaceuticals is being acquired Celgene, the companies said this morning, in a deal worth up to $485M. Celgene said it would pay $100M in cash and up to $385M in contingent payments for Quanticel, which devel...

San Carlos-based Natera, a provider of non-invasive, genetic testing services, said earlier this week that it has raised $55M in a financing round. The financing was led by Sofinnova Ventures, and also included Capital Research and Manageme...

Sunnyvale-based EBR Systems, which is developing wireless cardiac pacing system for treating heart failure, has raised $20M in a funding round, the company said this morning. The funding was led by Emergent Medical Partners, and also includ...

San Francisco-based Joyable, a startup developing technology it says helps people overcome social anxiety, has raised $2.1M in a seed funding round. The funding came from Thrive Capital and Harrison Metal. The startup, co-founded by Peter S...

Palo Alto-based Glooko, the developer of mobile apps to help diabetes patients manage their health, has raised $16.5M in a Series B funding round, the company revealed this morning. The funding came from Canaan Partners, Medtronic, and Soci...

San Mateo-based Allergen Research, which is developing desensitization treatments for food allergies, said Thursday that it has raised $80M in a Series B funding. The biopharmaceuticals firm said the funding goes towards a Phase 3 clinical ...

South San Francisco-based Lyric Pharmaceuticals, a company developing therapeutics for gastrointestinal diseases, said last week that it has raised $20.4M in a Series A financing round. The funding was led by Rivervest Venture Partners, San...

San Carlos-based Flexus Biosciences, which is developing cancer therapeutics, has been acquired by Bristol-Myers Squibb. The deal is worth $1.25 billion, split between $800M upfront and earnout worth up to $450M. Flexus Biosciences was vent...

Foster City-based Lifecode, a developer of gene sequencing-based molecular diagnostics products, said last week that it has raised $20.5M in a funding round. The funding was led by Sequoia Capital, the Mayo Clinic, and Mayo Ventures. Lifeco...

Brisbane, California-based Dance Biopharm, which is developing an inhaled insulin product to treat diabetes, said this morning that it has raised $9.5M in a funding round. The funding came in the form of convertible note and warrants. The c...

San Francisco-based Invuity, which develops lighting devices used in surgery to assist surgeons in minimally invasive surgery, has raised $20M in a new funding round, the company said this morning. The funding was led by Wellington Manageme...

Portola Valley-based DigiSight, a developer of remote patient monitoring tools for the opthalmic industry, said late Monday that it has raised $7.8M in a Series B funding round. The funding came from Biosys Capital, Waycross Ventures, GE Ve...

Menlo Park-based Armetheon, whic is developing biopharmaceuticals aimed at replacing the anticoagulant warfarin, said Thursday that it has raised $24.3M in a Series B funding round. The funding came from Hercules Bioventure Partners and Cap...

San Francisco-based 3Scan, which is developing a new, scanning microscope aimed at pathologists, said today that it has raised $6.67M in a funding round. The Series A funding was led by Lux Capital. 3Sca is led by Todd Huffman. The company ...

Fremont-based Zosano Pharma, which develops a transdermal drug delivery system, is expected to price its IPO on Tuesday, January 27th, according to industry information. The company has filed for an IPO as ZSAN on the NASDAQ Capital Market....

San Francisco-based Augmedix said this morning that it has raised $16M in a Series A funding, to bring healthcare applications to Google Glass. The funding was co-led by Emergence Capital and DCM Ventures, both of whom were seed investors i...

South San Francisco-based biopharmaceuticals firm Global Blood Therapeutics said this week that it has raised $48M in a Series B funding. The funding came from Wellington Management Company LLP, RA Capital, Deerfield Management, Sabby Capi...

South San Francisco-based Sequenta, which develops immunosequencing products, has been acquired by Adaptive Biotechnologies. Financial details of the buy were not anounced. Adaptive Biotechnologies was advised by J.P. Morgan and DLA Piper i...

Berkeley-based Caribou Biosciences has snagged equity funding from Novartis, as part of a deal where Norvatis will use Caribou's technology for drug target screening and validation, the two said this week. Size of the funding round was not ...

South San Francisco-based biotech CytomX said this morning that it has raised $20M more, in a Series C funding round. The round was led by Pfizer Venture Investments, and also included Third Rock Ventures, Canaan Partners and the Roche Vent...

San Francisco-based Symic Biomedical, a developer of therapeutics for chronic disease, has raised $15M in a Series A funding round. The funding was led by Lilly Ventures, and also included Den Danske Forskningsfond, Mitsui Global Investme...

San Francisco-based First Opinion, which develops a mobile app that lets users get remote, personal health consultations from physicians, has raised $6M in a Series A funding, the company said yesterday. The funding was led by Polar Partner...

San Francisco-based Audentes Therapeutics, which is developing treatments aimed at a number of rare diseases, said this week that it has raised $42.5M in a Series B financing round. The funding was led by Deerfield Management, and also incl...

Mountain View-based PneumRx said today that it has agreed to be acquired by BTG Plc, in a deal worth up to $475M. The developer of a minimally invasive, medical device to treat emphysema, said the deal is split between $230M upfront plus $2...

Mountain View-based Restoration Robotics, a developer of robotic surgery devices which harvest and transplant hair for treating baldness, has raised $45M in a funding round. The Series C funding was first disclosed in a regulatory filing, a...

Menlo Park-based Topera, a developer of electrophysiology technology used to treat atrial fibrillation, has been acquired by Abott, Abbott said this morning. Abbott said it will pay $250M upfront, plus unspecified earnout for Topera. Topera...

San Francisco-based Vida, a developer of mobile apps which provide 24/7 health coaching, has raised $5M in a Series A funding, the company disclosed today. The funding came from Aspect Ventures, Khosla Ventures, AME Cloud Ventures, Signia V...

Campbell, California-based ZipLine Medical has added $5.7M to a current, Series C financing round, the company announced this morning. Zipline said the extension to its round came from China Materialia, and also included RA Capital Manageme...

San Leandro-based MID Labs said today that it has raised $51M in funding for its medical devices. The company, which develops products for vitreoretinal surgery, said the funding was led by OrbiMed and Frontline BioVentures, and also includ...

San Francisco-based Invitae, a provider of genetic testing services for hereditary disorders, said today that it has raised $120M in a funding round. The Series F funding came from The Broe Group, Decheng Capital, Deerfield Management LLC, ...

San Mateo-based Allakos, a biotechnology company developing antibody-based therapeutics for allergic diseases, inflammation, and other related conditions, said today that it has raised $10M more in a Series A funding. The new funds bring it...

Palo Alto-based Jiff, a developer of cloud-based tools to help employees of self-insured employers better manage their health, has raised $18M in a Series B funding round. The funding came from Venrock, Aberdare Ventures, and Aeris Capital....

South San Francisco-based biopharmaceuticals developer Calithera Biosciences has set its estimated IPO range, saying in a filing that it now expects to price at between $13.00 and $15.00 per share. The company is selling 6 million shares of...

Palo Alto-based Livongo Health, a company developing a service to help patients manage chronic conditions such as diabetes, has raised $10M in a funding round, the company said this week. The funding came from 7wire Ventures and General Cat...

Menlo Park-based Armetheon, a developer of biopharmceuticals aimed at treating cardiovascular conditions, has raised $7.0M in a first round of funding. The company said that the round was co-led by AshHill Biomedical Investments and Hercule...

Mountain View-based Omnicell said this morning that it has completed its acquisition of Surgichem Limited, which is a subsidiary of Bupa Care Homes (CFG) plc. Financial details of the buy were not announced. Omnicell is a provider of medica...

Redwood City-base dDermira, a biopharmaceuticals firm focused on medical dermatology, said this week that it has raised $51M in a Series C funding round. The funding came from Bay City Capital, New Enterprise Associates (NEA), Canaan, and U...

San Francisco-based Nirmidas Biotech, a company developing technology for detecting disease biomarkers, has raised $2m in a seed funding round. The company--which is based on research out of Stanford--said the funding came from the Stanford...

San Francisco-based Acupera said this morning that it has raised $4M in a financing round, for its clinical analytics and workflow engine for the healthcare industry. The funding came from Lightspeed Venture Partners and The Whittemore Coll...

Redwood City-based PaxVax, a developer of vaccines for infectious disease, has raised $62M in funding, split between $50M in secured debt financing and $12M in an extension of its Series B funding round. The company said the debt financing ...

Menlo Park-based Virobay, which is developing pharmaceuticals to treat neuropathic pain, autoimmune disease and fibrosis, has raised $8M in an additional, Series B funding. The funding came from Perceptive Advisors, as well as existing inv...

Menlo Park-bsaed Emerald Therapeutics said Tuesday that it has raised a new round of funding, bringing its total raised to a total of $13.5M. The funding was led by Founders Fund and Max Levchin, and also included Schooner Capital. Emerland...

San Francisco-based Consano Medical, a developer of medical devices focused on the intelligent monitoring of intensive care unit patients, has raised $3.9M in a Series A funding, according to deal funding site Deal Labs. Source of the fundi...

South San Francisco-based biotechnology developer True North Therapeutics said yesterday that it has raised $22M in a Series A funding round. The funding came from Kleiner Perkins Caufield & Byers, MPM Capital, SR One, Biogen Idec New Ventu...

Hayward-based Chrono Therapeutics, which is developing products to help patients with quitting smoking, said Thursday that it has raised $32M in a Series A funding round. The funding came from Canaan Partners, 5AM Ventures, Fountain Healthc...

San Francisco-based MedGenome, which is using genetic information in India to better treat cancer in that country and elsewhere, has raised $4M in a Series A funding. THe company said the funding was led by Papillon Capital and Emerge Ventu...

Redwood City-based Proteus Digital Health, a developer of software which connects patients, families, and caregivers, has raised $120M in a new funding, the company said Monday. The company said the funding came from major, new institutiona...

Fremont-based AngioScore, a devleoper and manufacturer of balloon catheters used for cardiac surgery, has been acquired by Spectranetics, the two said Tuesday. Spectranetics will pay $230M plus unspecified earnout for AngioScore. AngioScore...

San Francisco-based Twist Bioscience has raised $26M in a Series B financing, the company announced today, to go towards its semiconductor-based, synthetic DNA manufacturing technology. The funding was led by Nick and Joby Pritzker, through...

San Francisco-based iRhythm Technologies said today that it has raised $17M in a Series E financing round. The company, which develops products for continuous monitoring of cardiac arrhythmia, said the funding was led by Novo A/S, and also ...

San Francisco-based Mango Health, a developer of software that uses gamification and social gaming to encourage health in patients, announced this morning that it has raised $5.25M in a Series A funding. The funding was led by Kleiner Perki...

Los Altos-based Altos Solutions, a developer of web-based, electronic medical records software, has been acquired by Flatiron Health. Financial details of the acquisition were not disclosed. Altos Solutions develops cancer/oncology focused ...

San Mateo-based EndoGastric Solutions, a developer of reconstructive treatments for gastroesophageal reflux disease (GERD), has raised $30M in a new funding round, the company said this week. The funding came from existing investors, includ...

South San Francisco-based Counsyl, a provider of inherited, cancer screening testing services, said this week that it has raised $28M in a Series D financing round. The company said the new funding was co-led by Rosemont Seneca Technology P...

Santa Clara-based ProteinSimple has filed for an IPO, saying yesterday that it is looking to raised up to $86.25M in an IPO on the NASDAQ Global Select Market as PRTN. The startup--which develops protein analysis software and tools--is vent...

San Francisco-based Doximity, which operates an online, private social network specifically for doctors, has raised $54M in a funding round, the company said Tuesday. The Series C funding round was co-led by Draper Fisher Jurvetson and T. R...

San Jose-based SI-BONE, a developer of medical devices used for back surgery, has raised $33M more in funding, the company said today. SI-BONE said the funding came from Orbimed and Novo A/S, and also included prior investors Skyline Ventur...

Redwood City-based Guardant Health has raised $30M in a Series B funding, to go towards development of a no-invasive, tumor sequencing test. The funding was led by Khosla Ventures, and also included Sequoia Capital and Perjman Mar Ventures....

South San Francisco-based Principia Biopharma said yesterday that it has raised $50M in a Series B funding round. The company, which is developing small molecule biopharmaceuticals aimed at treating autoimmune diseases, said the funding was...

San Francisco-based One Medical Group, which operates a network of doctor's offices aimed at primary care, has raised $40M in a funding round. The new funding came from Redmile Group, and also included Google Ventures, Benchmark, DAG Ventur...

Menlo Park-based Forsight VISION5, a developer of ocular inserts for treating glaucoma, dry eye, and allergy, said yesterday that it has raised $15M in a Series C funding round. The funding came from H.I.G. BioVentures, as well as Morgentha...

South San Francisco-based Iconic Therapeutics announced this morning that it has raised $20M in a Series B-1 funding round. The funds came from MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures. Iconic Therapeutics is developing tr...

South San Francisco-based Alios BioPharma said Monday that it has raised $41M in a Series B funding round. The funding came from Novo Ventures, SR One, Roche Venture Fund, and Novartis Ventures. A new, undisclosed investor led the round. Al...

Burlingame-based Reflexion Medical has snagged $11.6M in a Series A funding, for the company's medical devices for radiation therapy for treating cancer. The funding came from Sofinnova Partners, and also included Pfizer Venture Investments...

Menlo Park-based Transcend Medical, a developer of micro-stents used to treat glaucoma, has raised $22M in a Series C funding. The company said the funding came from existing investors, as well as an un-named, global pharmaceutical and medi...

Lafayette, California-based Providence Medical Technology, a developer of medical devices for the cervical fusion and back surgery market, has raised $6.8M in a Series C funding round. The funding came from Stanmore Medical Investments via ...

San Francisco-based PipelineRx, which provides outsourced, telepharmacy services to hospitals--allowing them to access remote pharmacists by phone to bolster onsite clinical pharmacists--has raised $5M in a strategic investment from AMN Hea...

South San Francisco-based Achaogen raised $72M in its IPO, and was up in trading during the day, after debuting at $12 per share this morning on the NASDAQ Global Market as AKAO. The company, which develops antibiotics aimed at drug-resista...

Moutain View-based Versartis, a biopharmaceuticals firm developing treatment for endocrine disorders, has set its IPO range at between $16.00 and $19.00 per share. The startup said it is looking to list on the NASDAQ Global Market as VSAR. ...

San Francisco-based Castlight Health, which develops cloud-based enterprise healthcare management software, has upped its IPO pricing range, saying in a filing that it now expects to IPo at between $13.00 and $15.00 per share. The company i...

Palo Alto-based Norwest Venture Partners (NVP) is backing a New York-based company which provides cardiac safety assessment services, iCardiac, the two said today. Size of the investment was not disclosed. iCardiac said that they are in a p...

Sunnyvale-based Miramar Labs, a medical device manufacturer developing products to reduce excess sweat production, said yesterday that it has raised $10M in a Series D funding. The funding came from Aisling Capital, Cross Creek Capital, Dom...

San Francisco-based Jaguar Animal Health, a developer of prescription pharmaceuticals and nutraceuticals for the veterinary marketplace, said it has raised $2M in a funding round. The fundin came from BioVeda China Fund. According to Jagura...

San Francisco-based private equity investor Thoma Bravo said this morning that it has acquired GHX, a provider of healthcare supply chain software and services. Financial details of the acquisition were not announced by the companies. GHX, ...

Menlo Park-based venture investor New Enterprise Associates said this week that it has hired on Elliot Sigal, M.D., Ph.D., as a new Venture Partner and Senior Advisor, significantly bolstering the company's expertise in the pharmaceuticals ...

Palo Alto-based Glooko, a developer of mobile apps to help patients manage diabetes, has raised $7M more in its Series A, via a Series A1 round, the company disclosed this week. The funding came from Samsun venture Investment Company and Li...

San Mateo-based Lumiata, a developer of predictive analytics software for the the healthcare industry, reported today that it has raised $4M in a Series A financing. The financing came from Khosla Ventures. Lumiata was formerly known as MED...

San Francisco-based big data analytics software developer Zephy Health said today that it has raised $15M in a funding round, for the company's platform aimed at life sciences companies. The startup said the funding was co-led by Kleiner Pe...

San Jose-based Alverix, a developer of point-of-care diagnostic instruments, has been acquired in a $40M deal by BD (Becton, Dickinson and Company). According to BD, it has been using Alverix' instruments since 2008, as part of a collaborat...

Redwood City-based pharmaceuticals developer AcelRx Pharmaceuticals said this morning that it has received a $40M credit facility from Hercules Technology Growth Capital. Terms of the new credit facility were not announced. AcelRx is develo...

San Francisco-based SoundHawk, which develops "smart" wireless hearing devices which connect hearing aids with a smartphone, has raised $5.7M in a funding round, the company announced Wednesday. The funding was led by True Ventures. The com...

Hayward-based Solta Medical has been acquired by Valeant Pharmaceuticals, in a deal worth approximately $250M. Valeant said it will pay $2.92 per share in cash for Solta, which develops aesthetic medicine medical devices, including RF devic...

Mountain View-based HealthLoop, a developer of a cloud-based platform for automating follow up care for physicians, has raised $10M in a Series A funding. The funding came from Canvas Venture Fund, which is managed by Morgenthaler Technolog...

San Francisco-based health technology and electronic health records software provider Practice Fusion said this morning that it has raised $15M in a Series D funding round. The round was led by Qualcomm Incorporate, via its venture arm, Qua...

Redwood City-based GenapSys said this week that it has raised $37M in a funding round for its gene sequencing platforms. The Series B funding came from Decheng Capital, IPV Capital, Yuri Milner, Stanford StartX Fund, and others. The company...

South San Francisco-based Veracyte debuted this morning in its IPO, and was trading slightly down after pricing at $13.00 per share lsat night. Veracyte was trading around $12.95 in morning trading, after its IPO as VCYT on the NASDAQ Globa...

South San Francisco-based Calithera Biosciences, a developer of cancer therapeutics, has raised $35M in its Series D funding round, the company announced. The company said the funding was led by Adage Capital Partners, and also included Lon...

San Francisco- and Seattle-based Immune Design said this morning that it has raised $49M in a funding round, to go towards its immune-based therapies for cancer and other conditions. The Series C funding came from The Column Group, and also...

Santa Clara-based NextBio, a developer of big data platforms for the clinical and genomic information market, has been acquired by life sciences equipment giant Illumina. Financial terms of the acquisition were not announced. Illumina said ...

Menlo Park- and Bellevue, Washington-based medical device manufacturer Kona Medical said Monday that it has raised $10M in a Series D, equity financing round. The round came from Chinese investment firm Morningside Group, which was the sole...

Had too much to drink? Burlingame-based Breathometer, a developer of a breathalyzer which connects to your smartphone, said this week that it has raised $2M in a seed funding round. The round came from Structure Capital VC and Dillon Hill C...

Burlingame-based Biodesy has raised $15M in a funding round, for its protein analysis systems, the company said this week. According to the company, the Series A funding came from 5AM Ventures, Pfizer Venture Investments, and Roche Venture ...

Pleasanton-based Veeva, a developer of cloud-based software for the life sciences industry, surged its its IPO, and is now trading as high as $38.00--up 85 percent from its IPO price of $20.00 per share. The company--which is backed by Emer...

Mountain View-based Amaranth Medical, which is developing bioresorbable, coronary scaffolds use for treating coronary artery disease, said this week it has raised $20M in a Series B funding. The funding came from DCP Management of Singapore...

Menlo Park-based Personalis, a developer of genome sequencing and interpretation services, has raised $22M in its Series B financing round. The company has now raised over $42M for its services. The new funds were led by Abingworth Manageme...

Los Altos-based Boreal Genomics, a developer of scientific equipment used to detect and monitor mustations in plasma due to cancer, said last week that it has raised $18M in a Series C funding round. The funding came from Arch Venture Partn...

Redwood City-based Relypsa has filed for an IPO, saying that it is looking to raise up to $126.5M in its initial public offering on the NASDAQ Global Market. The company, which is developing non-absorbed polymeric drugs to treat disorders i...

Menlo Park-based SafeShot Technologies, a developer of medical technology designed to pre-fill medications into syringes, has raised $6M in a funding round. The company said the funding came on top of an earlier, $3M funding it completed in...

Palo Alto-based Neurotrack announced today that it has raised $2M in a Series A funding round. The funding came from Founders Fund, and also included The Social+Capital Partnership. Neurotrack is working on biomarker technology to help diag...

Palo Alto-based health startup Simplee is trying to help patients better manage and understand their medical bills, and now has $10M to help in its quest. The company said this week that it has raised $10M in a Series B funding, led by Heri...

San Francisco-based healthcare software provider Practice Fusion said this morning that it has raised $70M in a Series D financing round, bringing its total raised to $134M. The new funding was led by Kleiner Perkins Caufield & Byers, and a...

South San Francisco-based Veracyte has filed for an IPO, saying that it is looking to raise up to $74.75M in its initial public offering. The company says it plans to debut on the NASDAQ Global Market as VCYT. The company's IPO is being und...

Saratoga-based VisionCare Opthalmic Technologies, a developer of medical devices to treat end-stage Age-Related Macular Degeneration (AMD), says it has raised $15M in funding in a debt round. According to the company, the capital came from ...

Pleasanton-based Veeva, a developer of cloud software for the life sciences industry, has filed for an IPO, and is looking to raise up to $150M on the public markets. The company said it has applied to list on the New York Stock Exchange as...

Richmond-based Sangamo BioSciences announced Monday that it is acquiring Ceregene, a biotechnology firm developing adeno-associated virus (AAV) gene therapies. Sangamo said it will issue 100,000 shars of its common stock, plus provide unsp...

Richmond-based Sangamo BioSciences announced Monday that it is acquiring Ceregene, a biotechnology firm developing adeno-associated virus (AAV) gene therapies. Sangamo said it will issue 100,000 shars of its common stock, plus provide unsp...

San Francisco-based biopharmaceuticals firm Onyx Pharmaceuticals has been acquired by fellow biotech developer Amgen, in a deal worth $10.4 billion. Amgen said it would pay $125 per share in cash, or $9.7 billion net in estimated cash at ha...

SynapDX, which is developing blood test to enable diagnosis of Autism Spectrum Disorders (ASD), has raised $15.4M in funding, led by Google Ventures. According to SynapDx, the funding also included North Bridge Venture Partners and General ...

South San Francisco-based NGM Biopharmaceuticals said last week that it has raised $50M in a Series C funding round, to go towards its development of therapeutics for the treatment of diabetes, obesity and other cardio‐metabolic disea...

Redwood City-based OncoMed Pharmaceuticals has increased the number of shares it is offering its IPO, boosting the number of shares in its offering to 4.8 million shares. No other terms of the IPO have changed. OncoMed Pharmaceuticals devel...

Santa Clara-based Optimedica, a developer of laser-based, opthalmic surgery devices, has been acquired by Abbot Medical Optics in a deal worth $250M in cash, plus up to $150M in earn out milestones. Optimedica is venture backed by Alloy Ven...

Palo Alto-based Comprehend Systems, which develops software to manage clinical trails, has raised $8.4M, the company said this morning. The Series A funding came from Sequoia Capital, and also included angels Aaron Levie, Nils Johnson, Zod ...

Redwood City-based Breakthrough announced this morning that it has raised $5M in a Series A funding, for its online counseling and psychiatry service. The funding came from Social+Capital Partnership, along with First Round Capital and Grea...

Fremont-based Zyomyx, a developer of portable, medical diagnostics platforms initially aimed at HIV/AIDs, has raised $12M in a Series 2 funding. The firm said the funding was led by Mylan, and also included conversion of funding from the Bi...

South San Francisco-based biotechnology developer Sequenta has raised $20M in a Series C funding, the firm said today. Sequenta said the round was led by Foresite Capital Management, and also included Mohr Davidow Ventures and Index Venture...

South San Francisco-based molecular diagnostics firm Veracyte has raised $28M in a Series C funding. The firm said the funding included GE Ventures, as well as Domain Associates, Kleiner Perkins Caufield & Byers, TPG Biotech, and Versant Ve...

Menlo Park-based 3-V Biosciencs, a biopharmaceuticals firm developing therapeutics for the oncology and infectious disease area, said Friday that it has raised $20M in a series C funding. The funding came from existing investors Kleiner Per...

Menlo Park-based ForSight VISION5 said Monday that it has closed its $9.3M, Series B-1 funding round. The firm, which is an offshoot of ophthalmic technology incubator Forsight Labs, said VISION5 is focused on treatments for ocular hyperten...

Palo Alto-based Anacor Pharmaceuticals, a developer of small-molecule therapeutics derived from a boron chemistry platform, has entered into a new, $45.0M loan agreement, the company said this week. The company said the loan comes from Herc...

Venture backed pharmaceuticals firm Pearl Therapeutics has been acquired by AstraZeneca in a deal worth up to $1.15 billion, the firms said today. Pearl Therappeutics is a developer of inhaled bronchodilator products for the treatment of pa...

San Leandro-based Mercator MedSystems has raised $6.5M in a Series B financing, the company announced this morning. Mercator MedSystems said the funding came from Volcano Capital, Crocker Capital, and Aphelion Capital, and also included Win...

San Francisco-based Jennerex Biotherapeutics has raised $21.6M in funding, the firm announced Thursday. Source of the private placement was not disclosed. Jennerex is developing oncolytic immunotherapies for solid tumors. The company said t...

Palo Alto-based ConsultingMD, which is developing an online service to connect patients with second opinions from medical experts, has raised $10M in a funding round. The round came from Venrock. The company said it will use the funds to fu...

Redwood City-based Proteus Digital Health has raised $62.5M in a Series F financing, the firm said Wednesday. The funding came from Oracle, Otsuka, Novartis, Sino Portfolio and the company's other investors. Proteus Health is developing "d...

Mountain View-based Conceptus, a developer of non-surgical, permanent birth control devices, has been acquired by Bayer Healthcare, the two announced this morning. According to the two, Bayer HealthCare has signed a merger agreement with CO...

Mountain View-based drchrono, which develops iPad applications for viewing electronic health records (EHR), said Thursday that it has received an investment from cloud storage provider Box. Financial details of the investment were not discl...

San Mateo-based Cervel Neurotech, a developer of medical devices which use magnetic coils to treat psychiatric and neurologic illnesses, said today that it has raised $14.1M in a new funding round. The funding came from D. E. Shaw Ventures ...

San Francisco-based iRhythm Technologies, a developer of patch-based, cardiac monitoring products, said today that it has raised $16M in a Series D funding round. The funding was led by Norwest Venture Partners, and also included New Leaf V...

Burlingame-based biopharmaceuticals developer Cleave Biosciences has raised another $10M in its Series A funding round, the firm announced today. According to Cleave, the new funding came from New Enterprise Associates. The funding brings i...

San Ramon-based SteadyMed Therapeutics, a developer of biopharmaceuticals to treat Pulmonary Arterial Hypertension (PAH), has raised $3M in a term loan from Square 1 Bank. Square 1 Bank said the loan will go towards working capital, to help...

Brisbane, California-based SARcode Bioscience said Monday that it is in an acquisition deal with Shire US Holdings, the global specialty biopharmaceuticals firm. SARcode said that Shire will pay $160M plus additional, undisclosed payments b...

San Francisco- and Boston-based Third Rock Ventures, which invests in healthcare companies, said Monday that it has raised $516M in its third fund, Third Rock Fund III. The firm said the fund was oversubscribed. The new fund brings its tota...

Menlo Park-based CardioKinetix said Thursday that it has raised $48M in a Series E financing, for its catheter-based heart failure therapies. The new funding round came from Panorama Capital, along with prior investors U.S. Venture Partners...

Hayward-based Solta Medical, the developer of medical aesthetics products, said this week that it has completed its acquisition of Sound Surgical Technologies. The deal was worth $25.5M in Solta common stock, $5.0M in cash, plus up to $9.5M...

Menlo Park-based Intersect ENT, which develops sinus implants used to treat ear, nose and throat patients, said today that it has raised $30M in a Series D round of funding. The round was led by Norwest Venture Partners, and also included ...

Redwood City-based Gynesonics, a developer of minimally invasive products for treating uterine fibroids in women, said today that it has raised $21M in a Series F funding round. The round was led by HBM Partners, and also included Correlati...

San Ramon-based Odyssey Thera, a developer of technology which measures disease pathways in human cells, said Thursday that it has raised $2.8M in funding. The funding came from HBM Partners, Burrill & Company, and Lonza. According to Odyss...

Hayward-based Solta Medical, which develops medical aesthetics products, has acquired SOund Surgical Technologies, in a deal worth $25.5M in stock, $5.0M in cash, plus up to $9.5M in earnout. Sound Surgical Technologies develops surgical an...

Mountain View-based MAP Pharmaceuticals, a publicly held developer of biopharmaceuticals aimed at treating migraines in adults, has been acquired by Allergan. The two said that Allergan will pay $25.00 per share for MAP, or approximately $9...

Palo Alto-based Syapse, which operates an online repository of human genome and clinical data, said this morning that it has raised a round of funding from The Social+Capital Partnership. Size of the funding round was not disclosed. Syapse ...

San Mateo-based Epocrates, the publicly held developer of mobile medical applications, has been acquired by Athenahealth, the two said this week. Athenahealth said it would pay $11.75 per share in cash, or approximately $293M, for Epocrates...

San Francisco-based Soltice Biologics said Friday that it has raised $18M in a Series A funding round. The firm, which is developing technology that enables the delivery of RNA-based therapeutics across membranes, said the funding was led b...

San Francisco-based Labrys Biologics, a biopharmaceuticals firm focused on treatments for chronic migraine, said this morning that it has raised $31M in a Series A financing round. The round came from venBio, Canaan Partners, InterWest Part...

Livermore-based Halt Medical has raised $15M in a funding round, which will go toward commercialization of its medical devices for treating uterine fibroids, the firm said this morning. Halt Medical said its system was recently cleared by t...

Redwood City-based Ascend Clinical, a provider of end-stage renal disease laboratory testing, has acquired the diagnostics laboratory business of PathCentral. Financial terms of the buy were not announced. PathCentral provides diagnostics t...

Palo Alto-based LUMO BodyTech, a developer of sensors, devices, and software which monitors a user's posture to help improve back health and reduce back pain, has raised $5M in a Series A funding round. The round was led by Madrona Venture ...

San Mateo-based Allakos said today that it has raised $32M in a Series A financing round, which will go towards its antibody therapeutics for treating allergic and inflammatory diseases. The funding was led by Novo Ventures, and also includ...

Mountain View-based 23andMe, the personalized genetics company led by Anne Wojcicki, said yesterday that it has received more than $50M in a new financing round. The round came from new investor Yuri Milner, and also included Sergey Brin, N...

Larkspur-based BioCision, which develops tools for the life sciences research and clinical research market, said today that it has raised $2.5M in a growth financing round. The round came from BroadOak Capital Partners, along with Research ...

Mountain View-based Edison Pharmaceuticals, a biopharmaceuticals firm developing treatments for mitochondrial diseases, has raised $20M in a Series F funding. The round was led by Mitsui & Co. Edison said the funding will go to advance clin...

Pleasanton-based TriReme Medical, a developer of medical devices for treating peripheral arterial disease, said today that it has raised $18M in a funding round. The round was led by Luminor Capital of Singapore, and also included other, un...

Hayward-based Intarcia Therapeutics announced Thursday that it has raised $210M in a combination of equity and debt. The developer of diabetes treatment said it raised $160M in a preferred stock private placement, and $50M in private debt. ...

Walnut Creek-based Beyond Lucid, a firm which helps provide tracking of documentation for the emergency response industry, said today that it has raised a "six figure" convertible note from Dalmore Investments. Exact amount of the funding w...

Remedy Informatics, a developer of clinical registries, medical research software, and research informatics for the life sciences industry, has raised $6M. The firm, which has offices in Menlo Park, said the funding came from the Merck Glob...

Redwood City-based Pearl Therapeutics said today that it has raised $65M in a Series D funding round. The round came from its existing investors, which include 5AM Ventures, Clarus Ventures, New Leaf Venture Partners, and Vatera Healthcare ...

San Francisco-based Drip Drop, a developer of medically forumlated, oral rehydration solutions used to treat dehydration and other issues, said today that it has raised a round of equity funding. Size of the funding round was not disclosed....

Hayward-based Advanced Cell Diagnostics said this morning that it has raised $12M in a Series B funding round. The firm, which is developing automated tools for detecting and quantifying RNA biomarkers, said the round was led by New Leaf Ve...

San Francisco-based Principia Biopharma, a pharmaceuticals firm developing small molecule drugs aimed at treating inflammatory, autoimmune diseases, and cancer, has raised $12.5M in a second tranche of funding. The funding came from New Lea...

Menlo Park-based venture capital investor Longitude Capital said today that it has raised $385M for its second, life sciences fund, Longitude Venture Partners II. The firm said it had targeted the fund at $325M. Longitude invests in growth ...

South San Francisco-based KaloBios Pharmaceuticals has filed for an IPO, saying that it is looking to raised $60M on the NASDAQ Global Market as KBIO. The firm's IPO is being underwritten by Leerink Swann, William Blair, and Needham & Compa...

Alameda-based Singulex, a developer of diagnostics tests for diagnosing and monitoring chronic diseases, has filed for an IPO, saying that it is looking to raised up to $86.25M on the New York Stock Exchange. The firm, whose initial tests a...

San Francisco-based Myokardia, a newly formed developer of small molecule therapeutics, said today that it is targeting genetic heart disease with $38M in funding. The Series A funding came from Third Rock Ventures. MyoKardia is developing ...

Redwood City-based Station X, a developer of software used for analyzing and visualizing genome data, has raised $5M in a second round of funding, the firm said today. The funding was led by Runa Capital, and also included Genomic Health. T...

Mountain View-based Complete Genomics has found a buyer for the firm, Chinese company BGI-Shenzhen. the two said this morning. The two said that they have entered into a definitive merger agreement where BGI Biotech will pay $3.15 per share...

San Mateo-based Doximity, developer of a mobile app driven, social networking platform for doctors, has raised $17M in funding. The funding was led by Morgenthaler Ventures. The new funding brings its total raised to $27.8M. Doximity is led...

San Francisco-based MyHealthTeams, which develops online, social networks specifically geared towards patients with individual, chronic health conditions, said today that it has raised $1.75M in a seed funding round. The round was led by Ad...

San Francisco-based CytomX Therapeutics, a developer of antibody therapeutics, said Tuesday that it has raised $41M in an expanded, Series B financing round. The round was led by Canaan Partners, and also included Third Rock Ventures and th...

San Francisco-based personalized DNA and genetics testing firm Navigenics has been acquired by Life Technologies, a developer of life sciences equipment. Financial terms of the acquisition were not disclosed. Navigenics was venture backed b...

Redwood City-based Avinger, a developer of medical devices used for treating peripheral artery disease (PAD), said yesterday that it has raised $33M in a Series D funding round. The firm said its existing major investors participated in the...

Hayward-based GenturaDx, a developer of molecular diagnostics products used for PCR analysis, has been acquired by Luminex Corporation. The deal was worth $50M in cash, plus unspecified earnout. GenturaDx was venture backed by Bay City Capi...

Santa Clara-based Benvenue Medical, a developer of minimally invasive products used for spine repair, said yesterday that it has raised $25M in a Series D funding round. The round came from existing investors DeNovo Ventures, Domain Associa...

San Francisco-based Practice Fusion, a developer of web-based, electronic medical records (EMR) software, announced this morning that it has raised $34M in a financing round. The round was led by Artis Ventures, and also included Felicis Ve...

San Francisco-based Gemmus Pharma, a developer of treatments for influenza, said today that it has raised a Series A funding. Size of the round was not disclosed. The round was led by Life Science Angels, and also included BlueTree Allied A...

Sunnyvale-based Aptus Endosystems, which is developing medical devices used for endovascular aneurysm repair (EVAR), said Wednesday that it has raised $25M in a equity funding round. The round was led by Synergy Life Science Partners, and ...

Redwood City-based EndoGastric Solutions, a developer of medical devices for treament of Gastroesophageal Reflux Disease (GERD), said Thursday that it has raised $13M in additional funding, a Series F extension for the company. The round c...

San Francisco-based Global Blood Therapeutics said this week that it has raised $40.7M in a Series A financing, for its efforts to develop oral, small molecule drugs for treating conditions such as sickle cell disease. The funding came from...

San Francisco-based Invuity, which develops surgical illumination and visualization technology, announced this morning that it has raised $25M in a Series D funding round. The funding was led by Valence Advantage Life Sciences Fund II, and ...

San Jose-based C8 Medisensors, a developer of medical devices which use light to measure blood glucose levels in people with diabetes, has raised $19M in a preferred stock financing, the firm said this week. Source of the funding was not an...

San Francisco-based CellScope, a developer of software that uses cellphone cameras to help diagnose pediatric ear infections, has raised $1M in a funding round, the firm said Monday. The seed funding came from Khosla Ventures. CellScope's s...

Burlingame-based Igenica, a developer of biopharmaceuticals focused on the cancer market, has raised $33M in a Series C funding round. The round was led by Third Rock Ventures, and also included The Column Group, Orbimed Advisors and 5AM Ve...

San Francisco-based AliveCor, which develops mobile electrocardiogram (ECG) devices, said today that it has raised $10.5M in a Series B funding round. The round was led by Burrill & Company and Khosla Ventures, and also included Qualcomm Ve...

San Francisco-based Ringadoc, a provider of service which allows users to call up doctors for medical device using their phone or computer, has raised $750,000 in a seed funding round. The firm said the funding came from FF Angel, Ryan Howa...

Menlo Park-based Auxogyn, a developer of health testing technology to test the viability of embryos during in vitro fertilization (IVF), has raised $18M in a Series B funding round, the company said today. The round was led by SR One, and a...

Mountain View-based Complete Genomics, the onetime high flying provider of whole human genome sequencing services, said today that it has cuts its staff, and has hired an investment banking firm to assist in "strategic alternatives." The fi...

Redwod City-based SentreHEART, the develope rof a medical device used for suturing soft tissue, has raised $26M in a Series C financing round, the firm announced. The round was led by Vivo Ventures, and also included US Venture Partners and...

Mountain View-based PneumRx, a developer of medical devices for minimally invasive treatment of lung disease, said it has acquired the patents and domain names from Broncus Technologies. Financial terms of the acquisition were not disclosed...

San Francisco-based Nurix, a stealth mode startup which looks to be headed by Timothy Kutzkey, a venture capitalist at The Column Group, has raised $3.1M in a funding, according to a regulatory filing by the firm. Details on what the compan...

Redwood City-based OncoMed Pharmaceuticals filed for an IPO Friday, saying that it is looking to raised up to $115M on the NASDAQ Global Market as OMED. The firm's IPO is being underwritten by Jefferies, Leerink Swann, Piper Jaffray, and...

Sacramento-based SynGen, which is developing stem cell harvesting systems for the regenerative medicine market, has raised $5M in a Series A funding. The round came from Bay City Capital. According to the firms, Bay City Capital will add tw...

South San Francisco-based Hyperion Therapeutics has filed for an IPO, saying that it is looking to raise up to $57.5M in an IPO on the NASDAQ Global Market. The firm has applied to list as HPTX. Hyperion is a developer of biopharmaceuticals...

South San Francisco-based KAI Pharmaceuticals, a biopharmaceuticals firm development treatment of secondary hyperparathroidism in patients with chronic kidney disease on dialysis, has been acquired by Amgen, the firms said today. Amgen said...

Redwood Shores-based Oracle said this morning that it has acquired ClearTrial, a developer of cloud-based, clinical trial tracking software. Financial terms of the by were not disclosed. Oracle said that ClearTrial's software helps make the...

Redwood City-based Relievant MedSystems, a developer of medical devices being targeted at treating low back pain, said today that it has raised $30M in a Series D funding round. The round was led by New Enterprise Associates, and also inclu...

Mountain View-based TheraVida, a developer of drugs to treat overactive bladder and urinary incontinence, has now raised $8.9M in its latest funding round, according to a recent regulatory filing from the firm. Details on the funding have n...

Redwood City-based Myoscience, a developer of medical devices which use cold to treat wrinkles, pain, and certain dermatologic conditions, said today that it has raised $33M in a Series D funding round. The round came from Accuitive Medica...

Livermore-based Halt Medical, a medical devices firm which is developing equipment to treat uterine fibroids, has raised $20M in debt and equity funding. The funding came from American capital, Ltd., along with other affiliates. Terms of th...

Palo Alto-based Varian Medical Systems, which manufactures medical devices and software for the radiotherapy, radiosurgery, and brachytherapy market, announced today that it has acquired InfiMed, a developer of workstations for processing d...

Menlo Park-based Health Fidelity said last week that it has raised a Series A funding round, to apply to its efforts to use natural language processing to mine for clinical healthcare data. The firm did not disclose the size of the funding....

Livermore-based HALT Medical, a developer of medical devices for treating uterine fibroids, announced today that it has raised $20M in the first part of an ongoing, $50M funding round.The firm said the debt and equity funding came from Amer...

Menlo Park-based Velomedix, which is developing medical devices which use hypothermia to treat cardiac arrest and stroke patient, has raised $10.2M in a Series B funding. Source of the funding was not announced by the company. As part of th...

Menlo Park-based Auxogyn, which is developing a system to improve invitro fertilization, said today that it has closed out its Series A round at $20M. According to the firm, the final tranche of its Series A included Kleiner Perkins Caufiel...

Mountain View-based drchrono, a developer of mobile healthcare software, including electronic health records, prescription, medical billing, and patient management tools, said last week that it has raised $2.8M in a funding round. The round...

Palo Alto-based Glooko, a developer of a mobile application and cables to pull and log information from glucose meters for the diabetic, has raised $3.5M in a Series A funding. The round came from The Social+Capital Partnership, along with ...

Saratoga-based VisionCare Opthalmic Technologies has closed an expansion of the firm's Series E financing, the company said this week. The funding was led by Agate Medical Investments. Size of the round was not disclosed. As part of the fun...

San Francisco-based Practice Fusion, which develops electronic medical records, said this morning that it has raised $2M more in funding for the company. The funding came from angels Jed Stremel (Facebook), Ali Partovi (LinkExchange), and H...

Redwood City-based Avinger, a maker of multi-functional catheters used for patients with Peripheral Artery Disease (PAD), said today that it has closed on $22.5M in a Series C funding. The round came from its existing investors, along with ...

San Jose-based Aria Diagnostics, a developer of molecular diagnostic test for prenatal and maternal health, reported this morning that it has raised $52.7M in a Series C funding round. The round came from Meritech Capital Partners, an un-na...

Menlo Park-based 3-V Biosciences, which is developing treatments for Hepatitus C (HCV), said this week that it has closed a preferred round of funding, worht a minimum of $20M. The round came from Kleiner Perkins Caufield & Byers and New En...

Emeryville-based Bionovo, a publicly held developer of pharmaceuticals for treating both menopause and cancer, said yesterday that it has raised $5M in a private investment. The funding came from Socius CG II, Ltd, a Bermuda-based investmen...

San Carlos-based PharmacoFore, a biopharmaceuticals firm working on compounds to treat diseases of the central and peripheral nervous systems, said Tuesday that it has raised $10M in an equity funding round. The round came from the Founders...

Pleasanton-based IntegenX, which is developing rapid human DNA identification technology, said this morning that it has raised $40M in a Series C funding. The funding was led by Essex Woodlands, and also included Domain Associates, QuestMar...

Mountain View-based Hansen Medical, a publicly traded developer of robotic catheters, said Friday that it has raised $30M in a debt facility. The funding came from Oxford Finance and Silicon Valley Bank. Hansen Medical said the financing wi...

Palo Alto-based HealthTap, a new startup which allows users to ask any health question online, and get an answer from a real doctor for free, announced today that it has raised $11.5M in a Series A funding. The funding was led by Mayfield F...

Santa Clara-based Affymetrix said Wednesday that it is acquiring eBioScience, a privately held developer of flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. The deal was worth $330M in cash. Priv...

Petaluma-based Tegal, a developer of a wide range of semiconductor and MEMs devices and technology, said this morning that it has invested $300,000 in NanoVibronix, an Israeli ultrasound technology developer. NanoVibronix is developing low-...

Sunnyvale-based BARRX Medical, a developer of minimally invasive medical devices, said yesterday that it has agreed to be acquired by Coviden. The deal is worth approximately $325M, plus future earn out. BARRX develops endoscopy devices use...

South San Francisco-based Portola Pharmaceuticals announced Monday that it has raised $89M in a preferred stock financing round. The firm, which is developing therapeutics aimed at cardiovascular and autoimmune/inflammatory disease, said th...

San Carlos-based Live Leaf Biosciences, a startup developing plant-based treatments for diarrheal disease, antibiotic alternatives, and wound care, has raised $2.6M in a funding round, according to a regulatory filing from the firm. Detail...

Sunnyvale-based Pivot Medical, a developer of minimally invasive technologies for hip arthroscopy, said Tuesday that it has raised $32M in a series C funding round. The round was led by Adams Street Partners, and also included Delphi Ventu...

Palo Alto-based Comprehend, a developer of clinical data visualization, analytics, and reporting software for the clinical research industry, said today that it has raised $1.2M in a seed funding round. The round came from Y Combinator, S...

San Jose-based DFINE, a developer of minimally invasive radiofrequency therapies for treating vertebral fractures, announced today that it has raised $25M in a funding round. The funding came from OrbiMed Advisors, Prospect Venture Partners...

Hayward-based Solta Medical, a developer of medical aesthetics products, said this week that it has expanded a credit line from Silicon Valley Bank. The firm said it has expanded the line from $18M to $28M, with the new $10m under a secured...

Redwood City-based Ziosoft, a developer of software used for 4D and 5d medical imaging on supercomputers, has been acquired by Nantworks, a technology incubation and development firm run by Patrick Soon-Shiong, a billionaire investor in Los...

Eric Schmidt, the Executive Chairman and former CEO of Google, has backed an Indian developer of pharmaceuticals security technology. According to PharmaSecure, a developer of anti-counterfeiting technology for pharmaceuticals, it raised $3...

San Francisco-based goBalto, a developer of web-based, clinical research software, said today that it has raised an undisclosed amount of Series A financing. The Series A came from Aberdare Ventures and the West Health Investment Fund. A re...

Pleasanton-based ZELTIQ Aesthetics, the developer of an aesthetic medical product used for selectively reducing fat bulges, has set its initial IPO range, according to an updated S-1 from the company today. ZELTIQ said it estimates its IPO ...

SV Life Sciences, the venture capital investment firm with offices in Boston, San Francisco, and London, said Wednesday afternoon that it ha named Dr. Heiner Dreismann as a new Ventuer Partners. Dr. Dreismann has previously served at Roche ...

San Francisco-based SpineGuard, a developer of a medical device used by surgeons for minimally invasive spine surgery, said Tuesday that it has raised $6.2M in a funding round. The funding came from Credit Agricole Private Equity, Innoven P...

San Jose-based SI-BONE, which develops a minimally invasive surgical devices for treating the sacroiliac joint, said this morning that it has raised $16.0M in a financing round. The firm said the funds will go towards expansion of its clini...

Redwood City-based CardioKinetix, the developer of transcatheter implants used to treat patients with heart failure, has raised $44M, the firm said, in a Series E financing round. The funding came via two tranches, and was led by SV Life Sc...

Palo Alto-based Varian Medical Systems and Seattle-based Calypso Medical Technologies said Monday that Varian is acquiring Calypso for $10M, plus potential earnout. Calpyso is a developer of tumor tracking and motion management systems for ...

San Francisco-based Practice Fusion, a developer of electronic health records software, said today that it has raised $6M in a new funding round. The round came from Western Technology Investment, Scott Banister, Founders Fund, Morgenthaler...

Mountain View-based Edison Pharmaceuticals, a developer of treatments for inherited mitochondrial diseases and other rare and neglected diseases, said today that it has raised a Series E preferred financing round. Financial details of the f...

South San Francisco-based Crescendo Bioscience, which develops molecular diagnostic tests for rheumatoid arthritis and other inflammatory diseases, said today that it has raised $31M in a Series C equity funding, plus a $25M strategic inves...

Fremont-based Ardelyx, a biopharmaceuticals firm developing treatments for irritable bowel syndrome, kidney disease, and diabetes, said Tuesday that it has raised $30M in a Series B funding round. The round included New Enterprise Associate...

Kleiner Perkins Caufield & Byers is the lead investor in a developer of real time, location systems for the healthcare market. In an unusual move for Kleiner, the firm was a new investor in a Series F funding round for Awarepoint, who syste...

Mountain View-based Restoration Robotics, a medical device firm developing technology for harvesting hair follicles during hair restoration procedures, said last week that it has raised $41M in a Series C financing round. The round was led ...

San Francisco-based Second Genome, a firm developing microbial-based, personalized medicine products for the gastrointestinal disease area, said yesterday that it has raised $5M in a funding round. The round was co-led by Advanced Technolog...

San Carlos-based Verinata Health, a firm developing diagnostic test for monitoring maternal and fetal health, announced today that it has raised $48.5M in a Series C funding round. The firm said the round was led by Mohr Davidow Ventures, S...

Sunnyvale-based Intuity Medical announced this morning that it has raised $76M in funding, in a second close of a previously announced Series D funding. The new funding added Accuitive Medical Ventures, which joins the firm's prior investor...

Brisbane-based SARcode Bioscience, a firm developing treatments for inflammatory disease, said this morning it has raised $44M in a Series B financing round. The round was led by Sofinnova Ventures, and also included Rho Ventures, Alta Part...

Menlo Park-based Transcend Medical, which is developing opthalmic devices for treating glaucoma, has raised $51M in its Series B round, the firm said this week. The new funding came as part of a second tranche in the Series B round. The fir...

Sunnyvale-based Sorbent Therapeutics, a biopharmaceuticals firm targeting the cardiovascular and renal disease area, has raised $36M in a Series B financing round. The firm said the funding was led by Novartis Venture Funds, and includes ex...

Burlingame-based Redwood Bioscience, a firm focused on antibody-drug conjugates and peptide therapeutics, said today that it has secured new funding from Takeda Venturse. Amount of the funding was not disclosed. The firm said the funding wi...

Novato-based BioMarin Pharmaceutical said Thursday that it is in a deal to buy a 133,000 square foot, bulk biologics manufacturing plant from Pfizer. the plant is located in Shanbally, Cork, Ireland. BioMarin said it paid $48.5M for the pla...

Novato-based Ultragenx Pharmaceuticals said today that it has raised $45M in a Series A funding round. The round was led by TPG Biotech and Fidelity Biosciences, and also included HealthCap and Pappas Ventures. According to the firm, the fu...

Mountain View-based PolyRemedy, a developer of chronic wound care treatment systems, said today that it has raised $20M in a Series C funding round. The round was led by Delphi Ventures, and also included prior investors Advanced Technology...

Palo Alto-based ADVANCE MEdical, which is helping to commercialize pharmaceuticals and medical device technologies in Brazil and other Latin American countries, said Wednesday that it has raised $6M in a Series A financing round. The round ...

Alameda-based CoolSystems, the maker of an cold therapy system aimed at the athletics market, has raised $4.0M in what looks to be a convertible debt round still in progress. Details on the funding have not been announced by the company. Ac...

Santa Clara-based Cell Biosciences, a developer of scientific equipment for protein analysis, said Thursday that it has acquired Brightwell Technologies, in a deal worth $9M in cash. Brightwell was based in Ottawa, Ontario, and develops mic...

Sunnyvale-based U-Systems, a developer of ultrasound technology for breast imaging, said today that it has raised another $6.5M in funding. The firm said the new funding came from existing investors, which include iD SoftCapital Group, Lumi...

Santa Clara-based Crown Biosciences, a provider of clinical testing services for the oncology pharmaceuticals development market, said this mornign that it has raised $28.8M in a Series C financing round. The roun was led by OrbiMed Advisor...

Redwood City-based OncoHealth, a developer of tests for cervical cancer and other cancers caused by human papillomavirus (HPV) viruses, has raised $1.6M in a Series A investment, the firm said today. The funding included Sand Hill Angels, B...

Mountain View-based Xlumena, a developer of medical devices for the endoscopy market, said last night that it has raised $7M in a Series B financing round. The round was led by Aperture Venture Partners, and also included Western Technology...

Fremont-based AngioScore, a developer of angioplasty catheters, said Wednesday that it has raised $12M in new private equity financing. The financing game from Saints Capital, and also included Psilos Group Managers, Telegraph Hill Partners...

Santa Clara-based Benvenue Medical, which is developing minimally invasive products for spine repair, has raised $35.5M in a Series C funding roudn, the firm said today. The funding was co-led by Domain Associates and Technology Partners, a...

Palo Alto-based Nfocus Neuromedical, a firm developing treatments for brain aneurysms, has raised $7.5M as part of an ongonig, $12.5M funding round, according to a regulatory filing by the firm this week. No detail on the new funding was di...

San Francisco-based GoBalto, a startup developing web-based software for managing clinical trials, has raised $2.87M out of a $3.5M fundraising round. The funding was revealed in a recent regulatory filing. GoBalto is headed by Jae Chung. T...

Newark, California-based Oraya Therapeutics, a developer of noninvasive, robotically controlled systems for treating eye disorders, has raised another $15.875M in funding, according to a regulatory filing by the firm. The round comes on $5....

San Francisco-based Practice Fusion said earlier today that it has raised $23M in a Series B funding round. The provider of electronic health and medical records software said the funding was led by Founders Fund, and also included Artis Ca...

San Mateo-based Doximity, a health technology firm developing a service which allows doctors to use their iPhone, iPad, or Android device to connect with other physicians on patient treatment and referrals, has raised $10.8M in a Series A f...

Sunnyvale-based Tibion Corp., a developer of bionic legs for stroke victims, said yesterday that it has raised $10.175M in a new funding round. The funding was led by Three Arch Partners and Hambrecht & Quist Capital Management. As part of ...

Berkeley-based Plexxikon, a developer of drugs for the treatment of melanoma cancer with the oncogenic BRAF mutation, has been acquired by Daiichi Sankyo, in a deal worth up to $935M. The firms said that Japanese pharmaceutical firm Daiichi...

Sunnyvale-based Intuity Medical, a developer of technologies for diabetes management, said today that it has secured a $20M credit facility from Silicon Valley Bank and Oxford Finance. The firm said the debt funding will go towards completi...

Foster City-based Gilead Sciences said today that it is acquiring Calistoga Pharmaceuticals, a Seattle developer of inflammatory, autoimmune, and cancer drugs. Gilead will pay $375M plus up to $225M in earnout for Calistoga. Calistoga was v...

Santa Rosa-based Sonoma Orthopedic Products, a developer of medical devices for treating fractures, said Monday that it has raised $22M in a Series D funding round. The round was led by Ascension Health Ventures, and also included Split Roc...

Pleasanton-based IntegenX, a provider of equipment used for preparing DNA and RNA samples for genetic analysis, said last week that it has raised $15.6M in a round of financing, and acquired GenVault Corporation. The funding round was led b...

San Francisco-based Massive Health, a stealth mode health care firm looking to apply crowdsourcing, game mechanics, and social networking to the healthcare field, has raised $2.25M in a seed funding round. The firm said the funding came fro...

San Mateo-based Epocrates surged in its IPO debut Wednesday, up to $21.42 after debuting on the NASDAQ as EPOC Wednesday morning at $16.00 per share. The firm sold 5,360,000 shares of its common stock. The IPO was underwritten by J.P. Morga...

South San Francisco-based Fluidigm has set the pricing range on its IPO, saying today in a filing with the SEC that it expects to offer 5,172,414 shares of its common stock at between $13.50 and $15.50 per share. Fluidigm is planning to lis...

Saratoga-based VisionCare Opthalmic Technologies, which develops visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD), said this morning that it has raised another $31M in a ...

Mountain View-based PneumRx, a developer of medical devices for treating lung disease, said today that it has raised $33M in working capital commitments. According to the firm, the new funding was led by Forbion Capital Partners and Endeavo...

San Francisco-based Pipeline Healthcare, a provider of remote order entry and other pharmacy services delivered via phone to North American hospitals and retail pharmacies, said Friday that it had raised $2.5M in a funding round. The fundin...

Pleasanton-based QuantaLife, a developer of PCR equipment for the genetic sequencing market, said Friday that it has raised $17.2M in a Series B financing round. The round came from Paladin Capital Group, Merieux Developpement, and Vital Fi...

San Francisco-based Sequenta, a developer of a molecular diagnostics platform focused on immune system profiling, said today that it has raised $13M in a Series B funding round. The round came from Index Ventures, Mohr Davidow Ventures, and...

San Ramon-based Estech, a developer of a minimally invasive cardiac ablation surgical platform, said today that it has raised $8.5M in a funding round. The funding came from Saints Capital Everest, Telegraph Hill Partners, NBGI Ventures and...

Los Gatos-based Sadra Medical, a developer of a fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis, has been acquired by Boston Scientific, the firms said Friday afternoon. Ac...

San Francisco-based Sutro Biopharma, a developer of protein therapeutics technology, said today that it has raised $36.5M in a Series C funding round. The round was led by Skyline Ventures, and also included Lilly ventures, Amgen Ventures, ...

Redwood City-based AcelRX Pharmaceuticals has filed for an IPO, saying in a filing with the SEC late Friday that it is looking to raise up to $86.25M on the NASDAQ Global Market. The firm said it is looking to list as ACRX. The IPO is being...

Mountain View-based Complete Genomics, a provider of gene sequencing services, has priced its IPO, saying in a filing Wednesday afternoon that it expects its initial public offering price to be $9.00 per share, and will offer up 6 million s...

Pleasanton-based Thoratec said today that it has sold its International Technidyne Corporation (ITC) division to private equity firm Warburg Pincus. The deal was worth $55M in cash. Thoratec said the sale will allow it to focus on its exist...

Redwood City-based Gene Security Network, a provider of molecular diagnostics products for single cell testing for chromosome abnormalities and genetic diseases, said today that it has raised $12M in a Series C funding round. The round was ...

Los Altos-based Vascular Pathways, a developer of medical devices targeted at peripheral intravenous access, said today that it has raised $14M in a Series B funding round. The round was led by CHL Medical Partners, and also included Ascens...

San Francisco-based healthcare services and IT firm McKesson Corporation said today that it is buying Texas-based US Oncology, an operator of cancer treatment centers. The deal is worth $2.16 billion in cash. McKesson said that the oncology...

Mountain View-based Nellix, a developer of treatments for abdominal aortic aneurysms, has been acquired. According to acquiring firm Endologix, it will pay $15M in stock plus up to $39M in milestone payments for Nellix. As part of the fundi...

Mountain View-based Complete Genomics, a provide of gene sequencing services, has set a pricing range for its IPO. The firm, which is looking to list on the NASDAQ Global Market as GNOM, said it expects its public offering price to be betwe...

Redwood City-based Pearl Therapeutics, a developer of biopharmaceuticals for treating chronic obstructive pulmonary disease (COPD) and other chronic respiratory diseases, announced this morning that it has raised $69M in a Series C financin...

Hayward-based Solta Medical, a developer of medical aethetics products, said today that it has acquired CLRS Technology, a provider of personal care solutions. Solta said it will pay approximately $1.1M of debt at closing, plus potential fu...

Santa Clara-based Cell Biosciences announced this morning that it has agreed to acquire Convergent Bioscience Ltd., a Toronto-based developer of protein analysis products, in a deal worth $12M. According to Convergent, the acquisition will ...

Pleasanton-based TriReme Medical, a developer of catheter and stent products, said today that it has raised $17M in a Series D funding round. The round was led by Bio*One Capital, and also included current investors Three Arch Partners and ...

Redwood City-based Pathwork Diagnostics, a developer of molecular diagnostics aimed at the oncology market, said today that it has raised $30M in a Series C financing round. The round was led by Alta Partners, and also included prior invest...

Silicon Valley venture capital firm VantagePoint Venture Partners has backed a New York-based developer of software for managing the patient check-in process for medical offices, Phreesia. Phreesia said VantagePoint led its $20M, Series D r...

San Francisco-based CytomX Therapeutics, a firm developing antibody technology, announced Thursday that it has raised $30M in a Series B funding round. The round was led by Third Rock Ventures, and also included the Roche Venture Fund. As p...

Sunnyvale-based Asthmatx, a developer of a less invastive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma, has been acquired by Boston Scientific, in a deal worth $193.5M in cash plus up to $25...

Boston-based Third Rock Ventures, a venture firm focused on life science companies, said this week that it has closed on Third Rock Fund II, a $426M fund focused on the life science area, and also opened up a San Francisco office. According...

Santa Clara-based Relypsa, a firm developing non-absorbable polymeric drugs for treating renal impairment, hypertension, diabetes and heart failure, said Monday that it has raised $70M in a Series B funding round. The round was led by OrbiM...

Palo Alto-based Anacor Pharmaceuticals, a biopharmaceuticals firm developing small-molecule therapeutics, has filed for an IPO. According to the firm's filing with the SEC, it is looking to raise up to $86.25M in an IPO on the NASDAQ Global...

Dublin, California-based TRIA Beauty, a developer of light-based skincare products based on lasers, said late last week that it raised $15.6M in a new round of growth financing. According to the firm, the round came from Aisling Capital, De...

Menlo Park-based venture capital firm Sofinnova Ventures announced today that it has added Garheng Kong, M.D., Ph.D., as a General Partners. Kong joins the company from Intersouth Partners, where he was also a General Partner. According to ...

Redwood City-based EndoGastric Solutions, a developer of treatments for upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD), announced this morning that it has raised $30M in a Series F financing round. The fun...

South San Francisco-based Solazyme, which is developing biotechnology that uses algae to produce renewable oil and bioproducts, said Thursday that it has added Bunge Limited as a strategic investors in its Series D round. Amount of the inve...

Mountain View-based Complete Genomics, a firm developing and commercializing a DNA sequencing platform, said today that it has raised $39M in a Series E funding round. The round was led by Sands Capital, and also included prior investors Es...

Novato-based BioMarin Pharmaceuticals said last night that it has acquired ZyStor Therapeutics, a biotech firm developing enzyme replacement therapies for treating lysosomal storage disorders. The deal is worth $22M upfront plus up to $93M ...

San Jose-based SI-BONE, a medical device firm developing a minimally invasive surgical device to treat the sacroiliac (SI) joint, said late Tuesday that it has raised $11.0M in a financing round. The round came from new investor Skyline Ven...

Ion Torrent, a developer of DNA sequencing technology, has been acquired by DNA giant Life Technologies, in a deal worth $375M in cash and stock plus up to $350M in earnout. Ion Torrent, which has offices in South San Francisco and headquar...

Solstice Neurosciences, a firm which as its production and manufacturing in San Francisco, but is based out of Malvern, PA, has been acquired. According to Kentucky-based US Worldmeds, it has acquired Solstice Neuroscience for $35M. US Worl...

Menlo Park-based Pacific Biosystems, a developer of tools for DNA, RNA, and protein analysis, has filed for an IPO. According to an S-1 filed by the firm this morning, it is looking to raise up to $200M on the NASDAQ Global Market as PACB. ...

Menlo Park-based Neodyne Biosciences, a stealth mode biotechnology firm developing technology related to plastic surgery and wound care, has raised $5.8M in funding, according to a recent regulatory filing. No details on the firm, nor its f...

Palo Alto-based Tenaxis Medical, a developer of surgical sealants, has raised $9.56M in a new round of funding, according to a regulatory filing by the firm this week. The funding appears to be part of an ongoing, $16.6M funding round for t...

Mountain View-based Complete Genomics, a provider of human genome sequencing services, said Friday that it has filed for an $86.25M IPO. The firm said it is looking to trade as GNOM on the Nasdaq. The IPO is being underwritten by UBS Invest...

Pleasanton-based Thoratec, a developer of ventricular assistant devices for patients with heart failure, said today that it has terminated its agreement to sell its International Technidyne Corporation (ITC) division to Danaher Corporation....

San Mateo-based Epocrates, a provider of drug reference information via mobile phones, has re-filed for an IPO. The firm said it is looking to raise up to $75M on the NASDAQ Global Market under the symbol "EPOC". The IPO is being underwritt...

Menlo Park-based Pacific Biosciences, a firm developing technology for the real-time detection of biological events, said Wednesday that it has completed a $109M, Series F financing. The round includes a previously announced $50m investment...

Sunnyvale-based BARRX Medical, a developer of treatments for Barrett's esophagas, a precancerous condition of the esophagus, said today that it has raised $15M in a Series D funding round. The round was led by Highland Capital Partners, and...

Santa Rosa-based Trivascular, a developer of medical stent graft systems for treating aortic aneurysms, said this week that it has raised $60M in a Series C funding round. The round was led by Pinnacle Ventures, and also included New Enterp...

Belmont-based Ventus Medical, a medical device firm developing a treatment for sleep apnea, said this week that it has raised $40M in a Series D funding round. Source of the new funding was not disclosed. Ventus also said it has named Peter...

South San Francisco-based iPierian, a firm developing stem cell-based biopharmaceuticals for the drug discovery market, said Thursday that it has raised $22M in a Series B equity funding. The round was led by Google Ventures, and also inclu...

San Jose-based DFine, which develops minimally invasive treatments for stabilizing vertebral fractures, said this week that it has raised $36.2M in a new round of funding. The round was led by Split Rock Partners, and also included Orbimed,...

South San Francisco-based Calithera Biosciences said today that it has raised $40M in a Series A financing round. The round was led by Morgenthaler Ventures, and also included U.S. Venture Partners, Advanced Technology Ventures, Delphi Vent...

Redwood City-based Incline Therapeutics, a specialty pharmaceuticals firm developing a transdermal, patient-controlled analgesia system for post-surgey patients, has scored $43M in a Series A venture financing. The firm said Monday that the...

Menlo Park-based Pacific Biosciences, a developer of DNA sequencing technology, has received $50M in an investment from Gen-Probe, the firms announced Thursday. According to the firm, the investment comes as part of a deal to co-develop new...

San Francisco-based Practice Fusion, a developer of electronic medical records software, said today that it has added angel investor and former Intuit exec Mark Goines to is baord of directors. Goines was most recently Senior Vice President...

South San Francisco-based Veracyte, a developer of molecular cytology diagnostic products, has raised $28M in a Series B round. The round was led by Domain Associates, and also included Kleiner Perkins Caufield & Byers, TPG Biotech, and Ver...

San Francisco-based Castlight Health, which delivers a web-based service to provide employees with information about health care benefits and costs, has raised $60M in a Series C funding. The firm said the round came from Morgan Stanley Inv...

Fremont-based Quark Pharmaceuticals, a developer of RNAi-based therapeutic products, announced Thursday that it has raised $10M in a funding round. The round came from Japanese firm SBI Holdings Group. As part of the funding, Quark said it ...

Pleasanton-based Zeltiq, a firm developing medical devices for fat reduction, announced yesterday that it has raised $25M in a Series D funding round. The round was led by Aisling Capital, and also included its prior investors Advanced Tech...

Mountain View-based Alexza Pharmaceuticals, a publicly held firm focused on treatment of central nervous system conditions, said today it has received a committed equity financing facility worth $25M. The funding comes from Azimuth Opporuni...

San Ramon-based Breathe Technologies, a developer of medical devices for trating chronic obstructive pulmonary disease and sleep apnea, said Tuesday that it has raised $23M in a Series C funding round. The round was led by DAG Ventures, and...

San Francisco-based iRhythm Technologies, which develops a cardiac rhythm monitor, has scored $10M in a funding from St. Jude Medical, Mohr Davidow Ventures, and Synergy Life Science Partners, St. Jude and iRhythm announced Thursday. Accord...

Mountain View-based Intuit said Monday evening that it has acquired Medfusion, a North Carolina-based firm providing online software for healthcare providers. The deal was worth $91M in cash. According to Intuit, the acquisition will accele...

San Mateo-based NeurogesX, a biopharmaceuticals firm focused on pain management, said today that it has entered into a $40M royalty financing agreement, from Cowen Healthcare Royalty Partners, L.P. According to the firm, the debt funding wi...

Palo Alto-based Viveve, a firm developing non-surgical, vaginal tissue restoration technology for women, has received $4.0M in a funding round, according to a regulatory filing from the firm this week. The firm is backed by 5AM Ventures and...

San Francisco-based Healthline Networks, which operates consumer related health information web sites, announced Tuesday that it has raised $14M in a third roudn of funding. The round was led by Investor Growth Capital. Peacock Equity Fund ...

Redwood City-based Codexis, a developer of biocatalysts for the pharmaceutical and biofuels industries, said today that it has priced its IPO at $13.00 a share. The firm is selling 6,000,000 shares of its common stock on the NASDAQ Global M...

Redwood Shores-based Oracle said Friday that it has acquired publicly held Phase Forward, a developer of software-as-a-service applications for collecting clinical trial data. Oracle said it would pay approximately $685M, or $17.00 per shar...

Menlo Park-based Amplyx Pharmaceuticals announced Thursday that the firm has raised $1.5M in a Series A funding round. According to the firm, the round came from Golden Seeds, a nationwide angel group investing in women-led companies, with ...

Mountain View-based IRIDEX Corporation, a developer of laser-based medical devices, said today that it has acquired the ophthalmology products of RetinaLabs, based in Atlanta. According to IRIDIX, the acquisition covers substantially all of...

San Francisco-based Achaogen, a biopharmaceuticals firm focused on developing antibiotics, announced today that it has raised $56M in a Series C round. The round was led by Frazier Healthcare Ventures, and included Alta Partners, 5 AM Ventu...

South San Francisco-based Altheos announced today that it has raised $20M in a Series A funding. The firm, which is licensing a set of compounds from Japanese firm Asahi Kasei Pharma for the topical treatment of glaucoma, said the funding w...

Sunnyvale-based U-Systems, a developer of automated breast ultrasound systems, announced Thursday afternoon that it has raised $10M in a funding round. The round was led by iD SoftCapital Group, and also included Sycamore Ventures, Lumira C...

Menlo Park-based Allocade, which develops healthcare software, said Wednesday that the firm has raised $5M in a venture funding round. The round was led by VantagePoint Venture Partners. Allocde said the funding will use to scale the firm's...

South San Francisco-based Poinard Pharmaceuticals, a publicly held biopharmaceuticals firm, said today that it has raised $6.3M in a share sale to Commerce Court Small Cap Value Fund, Ltd. The firm said the funding will go to fund continued...

South San Francisco-based NGM Biopharmaceuticals said today that it has closed on the first tranche of a $51, Series B round of funding. The round came from The Column Group, Tichenor Ventures, LLC, Prospect Venture Partners, Rho Ventures, ...

Hercules, California-based Eureka Genomics, a firm focused on using advanced bioinformatics analysis of genetic sequencing data to develop drugs, said Wednesday that it has raised $3.7M in a round of funding from private individuals and ang...

Redwood City-based Facet Biotech, a developer of treatments for multiple sclerosis, has been acquired by Abbott, in a deal worth $450M. According to Abbott, it will pay $27 per share in cash for Facet, for a purchase price of approximately ...

San Francisco-based Vaxart, a developer of oral vaccines, said today that it has raised $12.5M in a Series B funding round. The round was led by Care Capital. As part of the funding, Richard Markham and Jan Leschly of Care Capital have join...

Davis-based Gold Standard Diagnostics, a firm providing tools for the medical research and laboratory diagnostics industry, said Tuesday that it has raised a Series A round of funding. Amount of the funding was not disclosed. The firm said ...

San Mateo-based TwoF, a developer of proprietary technology for production of DNA microarrays, has raised $2.1M in an ongoing, $3.0M funding round, according to a regulatory filing by the firm this week. No details on the funding have been ...

San Francisco-based Mb>DNA Direct, a provider of information about genetics testing, has been acquired by New Jersey firm Medco Health Solutions. Financial terms of the buy were not disclosed. DNA Direct was venture backed by Firefly Invest...

Pleasanton-based Juvaris Therapeutics, which is developing adjuvanted vaccines for improving the effectiveness of influenza vaccination, said today that it has had a second close of its Series B funding worth up to $25M. The new funding cam...

San Francisco-based Vaxart, a developer of oral vaccines, has raised nearly $3.5M out of an ongoing $12.5M funding round, the firm disclosed in a regulatory filing Thursday. Source of the new funding was not disclosed. The firm's pipeline ...

Menlo Park medical device company incubator The Foundry reported Wednesday that it has received $3M in a Series A financing for its twelfth new company. Name of the new company--refereed to as "Foundry Newco XII"--was not disclosed. Accordi...

Menlo Park medical device company incubator The Foundry reported Wednesday that it has received $3M in a Series A financing for its twelfth new company. Name of the new company--refereed to as "Foundry Newco XII"--was not disclosed. Accordi...

San Jose-based Dfine, a developer of medical devices for treating spine fractures, has raised $2.83M out of an ongoing, $3.0M funding raising effort, according to a regulatory filing by the firm Monday. No details on the funding have been a...

Sunnyvale-based Neuralieve, a developer of a medical device for relieving migraine pain, has raised $3.89M out of an ongoing $7.5M fundraise, according to a regulatory filing by the firm. Source of the new funding was not disclosed, however...

Newark-based Revance Therapeutics announced today that it has raised $25M in the first close of a $35M, Series D financing round, confirming information first disclosed in a regulatory filing last week. According to Revance, the new funding...

Mountain View-based ReVance Therapeutics has raised $25.62M in a Series D funding, according to a regulatory filing by the firm last week. Source of the new funding was not disclosed. ReVance has previously received funding from Bio*One Cap...

Palo Alto-based Afferent Pharmaceuticals, a developer of chronic pain treatments, has raised $23M in a Series A financing round, the firm said today. The round was led by Third Rock Ventures and Pappas Ventures, and also included Domain Ass...

Soquel-based Monterey Devices, a stealth mode developer of a drug delivery system, has raised $2.5M out of a $7.0M funding round, according to a regulatory filing by the firm this week. The firm lists a representative of MOntage Capital, a ...

San Francisco-based private equity firm Francisco Partners reported Tuesday that it is acquiring QuadraMed Corporation, a provider of healthcare information technologies and services. The deal is worth approximately $126M in cash. Francisco...

Menlo Park-based 5AM Venture Management said Monday that it has raised $200M in 5AM Ventures III, L.P., the firm's venture capital fund focused on early-stage life sciences companies. The firm said the funding came from both current and new...

Redwood City-based EndoGastric Solutions, a developer of medical devices for treating gastroesophageal reflux disease (GERD), has raised $21.5M in a Series E funding round. The funding came from current investors. The company said that the ...

Santa Rosa-based TriVascular, a developer of stent graft treatments for abdominal and thoracic aortic disease, said this week that it has raised $30M in a Series B funding round. The firm said the funding came from New Enterprise Associates...

Pleasanton-based Microchip Biotechnologies, a developer of scientific equipment for sample processing in the life sciences and applied sciences area, announced today that it has raised $18.1M in a Series B financing. The round was led by Do...

Sunnyvale-based Labcyte, a developer of liquid handling equipment and lab instrumentation, has raised $5.5M in a venture debt funding. According to funding firm Hercules Technology Growth Capital, it provided the $5.5M as a credit facility ...

Menlo Park-based Spinal Modulation, a developer of medical devices for treating back pain, said Thursday that it has raised $27.4M in a Series C funding round. The round came from Johnson & Johnson Development Corporation, DeNovo Ventures, ...

Mill Valley-based Mytrus, a stealth mode firm which says it is "bringing clinical trials directly to participants," has raised $1.0M in a funding round, according to regulatory filings. No details on the funding have been released by the co...

South San Francisco-based Nodality has raised $3.5M out of an ongoing, $10M fundraising effort, according to a regulatory filing by the firm this week. The firm is developing personal diagnostics technology, specifically focused on detectin...

Palo Alto-based Aviir, a firm developing diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease based on research out of Stanford, has raised $1.0M in a combination of equity and debt, along with warrants. The ...

Emeryville-based Onyx Pharmaceuticals said today that it is in a definitive agreement to acquire South San Francisco-based Proteolix, a biopharmaceuticals firm focused on treating hematological malignancies and solid tumors. Onyx said it wi...

San Mateo-based Caring.com, which operates an online site about healthcare options and senior care for aging parents, said Wednesday that it has acquired Gilbert Guide, an online senior housing guide and homecare directory, as well as a pro...

Santa Rosa-based Direct Flow Medical, a developer of aortic tissue value prothesis, has scored $40M in a venture funding round, according to a regulatory filing by the firm. No details on the funding have been announced by the company. The ...

Mountain View-based Google Ventures, the venture capital arm of Google, has led an investment in Adimab, a New Hampshire firm focused on human antibody discovery. According to Adimab, Google was joined by Polaris Ventures, SV Life Sciences,...

San Francisco-based Jennerex, a developer of oncolytic virus therapeutics, said late last week that it has closed its second tranche of Series C funding. The firm said the round close dout at $5,611,475, above the firm's target of $5M. The ...

Burlingame-based Juvaris BioTherapeutics announced Thursday that the firm had a first close on a $25M, Series B financing round. The new funding was led by SV Life Sciences and Kleiner Perkins Caufield & Byers. The firm did not say what the...

Cupertino-based NextBio, which is developing an online platform for sharing information between life science researchers, said today that it has closed an $8M, Series C venture funding round. The round was led by Newbury Ventures, and also ...

San Carlos-based Alvine Pharmaceuticals, a biopharmaceuticals firm developing treatments for celiac disease, announced Tuesday that it has raised $21.5M in a Series A extension funding round. The funding was led by Panorama Capital, and als...

Menlo Park-based Evalve, a developer of minimally invasive cardiac valve repair technology, has been acquired by Abbott. Abbott said it would pay $320M in cash plus milestone payments, worth up to a total of $410M, for Evalve. Evalve was fo...

Foster City-based VitaPath Genetics, which is developing molecular diagnostics for detecting Spina Bifida, said today that it has raised $6M in a Series A funding round. The round was led by MDV-Mohr Davidow Ventures, and also included fun...

Santa Clara-based Cell Biosciences said late Tuesday that it has acquired Alpha Innotech Corp in a deal worth approximately $17.9M in cash. San Leandro-based Alpha Innotech develops digital imaging systems for genomic and proteomic research...

Biogen Idec said Friday that it has launched an effort to acquire Redwood City-based Facet Biotech, in a deal worth $14.50 per share in cash for Facet. According to Biogen Idec, the offer is approximately 64% over the September 3rd closing ...

Hayward-based Advanced Cell Diagnostics (ACD), a developer of cell- and tissue-based diagnostic tests for personalized medicine, announced late Wednesday that the firm has completed a second close on a $5.4M, Series A funding. The financing...

South San Francisco-based Fluidigm, a developer of integrated fluidic circuits for the life sciences industry, has raised $10.67M in a funding round, according to a regulatory filing by the firm today. The round is part of a ongoing, $14M f...

Emeryville-based Athena Feminine Technologies, which is developing treatments for female incontinence, announced today that the firm has raised $2M in a Series A investment round. The round came from vSpring Capital. The firm said that the ...

Mountain View-based Complete Genomics said today that it has raised $45M in a Series D financing round. The round was led by Essex Woodlands Health Ventures and OrbiMed Advisors, with existing investors Enterprise Partners Venture Capital, ...

Santa Clara-based OptiMedica, a firm developing medical laser technology for treating retinal disease, has raised $25M as part of a Series D funding round. The funding was disclosed in a regulatory filing. According to the filing, the firm ...

San Francisco-based Jennerex, a biopharmaceuticals firm developing oncolytic virus therapeutics targeted at treatment of liver, colon, and lung cancer, said this week that it has raised $5.1M in a funding round as part of a private placemen...

San Francisco-based Practice Fusion, a developer of web-based applications for patient health record tracking, disclosed this week that the firm has raised a round of funding from Salesforce.com. Amount of the investment was not disclosed. ...

Brisbane-based XDx, a firm working on molecular diagnostics, reported Wednesday that it has raised $14.4M in a Series G financing round. The round was led by Bristol-Myers Squibb, along with prior investors Burrill Venture Capital; Duff, Ac...

Signostics, which also has operations in Australia and an office in Palo Alto, said late Tuesday that it has raised $4M for the firm's personal ultrasound devices. The firm said the funding round came from Brandon Capital Partners, Playford...

Newark-based Novasys Medical, which develops a treatment for female stress urinary incontinence, reported today that it has raised $18.95M in a second tranche of its Series D funding round. The funding came from Versant Ventures, ThreeArch ...

South San Francisco-based Limerick BioPharma reported today that it has raised $15M in a Series C funding round. The round was led by OVP Venture Partners, and also included prior investors ARCH Venture Partners, Sevin Rosen Funds and Altit...

San Francisco-based Presidio Pharmaceuticals said Thursday afternoon that it has raised another $27M for the firm. The company, which is focused on developing treatments for viral infections, including HIV-1 and HCV, said the round included...

Fremont-based Zosano Pharma, which develops transdermal drug delivery technology, said today that it has raised $30M in a new roun dof financing. Zosano said that Nomura Phase4 Ventures led the round, with all of its existing investors part...

South San Francisco-bsaed iZumi Bio and Boston-based Pierian, two biotech firms focused on stem cell based therapeutics, said today that they have merged to form a new company, iPierian, and also raised funding worth $11.5M. The two said th...

Redwood City-based Relievant Medsystems reports today that it has raised $20M in a private equity financing round. According to Relievant, the round was led by Morgenthaler Ventures, and also included Canaan Partners, ONSET Ventures, and Em...

South San Francisco-based Hyperion Therapeutics, which is developing pharmaceuticals for the gastroenterology and hepatology areas, announced today that it has raised $60M in a Series C financing round. The round was led by Bay City Capital...

Menlo Park-based 5AM Ventures, a venture investor in the life sciences industry, has now hit $159.25M in its fundraising for 5AM Ventures III, according to a regulatory filing from the firm today. Details on limited partners in the fund hav...

San Francisco- and Paris-based SpineGuard, which is developing medical devices for back surgery, said this morning that it has raised $4M in a funding round from Delta Partners. According to the firm, the investment brings its Series A fund...

Mountain View-based Google disclosed Thursday in a regulatory filing that the firm has invested $2.6M in 23andMe, the genetic analysis firm headed by Sergey Brin's wife, Anne Wojcicki. According to Google, the investment came in 23andMe's S...

Redwood Shores-based Oracle said late Wednesday that the firm has acquired the intellectual property assets of Conformia Software. Financial terms of the acquisition were not disclosed. Conformia is a developer of product and process lifecy...

South San Francisco-based Alios BioPharma disclosed this morning that the firm has raised $32M in a Series A, preferred stock financing for the firm's biotechnology efforts. According to the firm, the round came from new investor SR One, th...

Menlo Park-based Apieron revealed Monday that the firm has received commitments from Alliance Technology Ventures, Canaan Partners, Draper Fisher Jurvetson and Onset Ventures--all existing investors in the firm--for a Series D round. Fundin...

Redwood City-based Versartis, a new joint venture between Amunix Inc. and Index Ventures, said today that it has raised $11M in a Series A financing round. The round came from index Ventures. According to the company, it was created to expl...

San Ramon-based Endoscopic Technologies, a developer of cardiac surgery devices, announced today that the firm has raised $8M in a n equity financing raise. According to the firm, the funding was led by NBGI Ventures, and also included Sai...

Clovis Oncology, a new biotech startup focused on commercializing anti-cancer agents, disclosed today that it has raised $145M for the firm. The firm, which has offices in San Francisco but is based in Boulder, Colorado, said the funding ca...

Menlo Park-based Autonomic Technologies, a stealth mode developer of implantable medical devices for treating severe headaches, has raised $20M in a Series B funding, according to lead investor Interwest Partners. Details on the funding hav...

Menlo Park-based venture capital firm Interwest Partners said today that it has made the first four investments from its tenth fund, InterWest X. According to InterWest, it led a $15M Series B financing for Exalt Communications, and co-led ...

Mountain View-based 23andMe, the personal genomics startup headed by Anne Wojcicki, has raised $11M of a $24.26M funding round, silicontap.com has learned. According to a regulatory filing, 23andMe raised the equity on April 16th. Details o...

Mountain View-based Google is looking to apply its search footprint to help track the interest in the swine flu outbreak, through an expansion of its Google Flu Trends service. According to Google, it is now breaking out searches for flu-re...

French biotech firm Sanofi-aventis said Wednesday that the firm has signed an agreement to acquire Brisbane, California-based BiPar Sciences. BiPar is a developer of cancer treatments. According to the firms, the deal is worth up to $500M, ...

Palo Alto-based Cell Biosciences, a developer of instrumentation systems for the life science industry, announced Thursday that the firm has raised $10M in a Series C round. The round was led by the Wellcome Trust, and also included prior i...

Berkeley-based Aerovance, a biopharmaceuticals firm focused on treatments for respiratory and inflammatory diseases, said Tuesday that it has raised $38M in an equity financing round. According to the firm, the round was led by ProQuest Inv...

Menlo Park-based Neuraltus Pharmaceuticals, which is developing small molecule drugs for treating neurodegenerative diseases, said this morning that it has raised $17M in a Series A financing round. According to the firm, the funding came f...

Redwood City-based Oracle announced this morning that it has agreed to acquire Relsys International, a developer of drug safety and risk management products for the health sciences industry. Financial details of the buy were not disclosed. ...

San Bruno-based Numerate, a biotech firm developing small molecule therapeutics, said Wednesday that it has raised $5.5M in a Series B funding. The company said that Foundation Capital led the round, which also included Lanza techVentures. ...

Mountain View-based 23andMe, the DNA testing startup co-founded by Anne Wojcicki and backed by Google, said Thursday that the firm is launching an effort to help advance research into Parkinson's disease. The firm said that it is in a colla...

Irving L. Weissman, M.D., an expert on stem cells, and Director of the Stanford Institute for Cancer/Stem Cell Biology and Medicine, has linked with a venture capital firm based in Seattle. According to OVP Venture Partners, Weissman joins ...

Pleasanton-based Arcxis Biotechnologies, which develops biomedical devices for extracting, isolating, and purifying RNA and DNA, said Thursday afternoon that the firm has scored an investment from In-Q-Tel, the venture capital arm of the CI...

Palo Alto-based Eiger BioPharmaceuticals Inc. announced Tuesday that its first round of venture financing has yielded $7.1 million. The firm credited InterWest Partners and Vivo Ventures with leading the Series A effort. Both investors hel...

South San Francisco-based Alios BioPharma, which is developing small-molecule and protein-based therapeutics, said Thursday that it has raise $8.4M in a Series A funding round. The firm said the funding is the first tranche in a commitment ...

San Francisco-based Linkage Biosciences disclosed Wednesday that the firm has raised $2M in a Series A funding round. The round was led by Greenhouse Capital Partners and James R. Fisher, who is a managing member of Fisher Capital Corp. II ...

Hayward-based Guava Technologies, which develops bench top cell analysis systems for the life sciences industry, has been acquired by Massachusetts-based Millipore, Millipore said today. According to Millipore, it will pay $22.6M for Guava....

Pleasanton-based Arcxis Biotechnologies, which is developing biomedical devices, said Friday that the firm has completed the first close of a Series B funding round. Amount of the funding was not disclosed. Arcxis said that Claremont Creek ...

Menlo Park-based Cantimer, which is developing senors for measuring human hydration from saliva, said Thursday that it has scored $1M in an equity investment. The funding came from Advanced Instruments Inc., and was part of a deal to collab...

Redwood Shores-based Omnitura, a biopharmaceutcals firm marketing multivalent drugs for the treatment of cancer, said Thursday that the firm has raised $24M in a private placement. The firm did not disclose investors, but said that the fina...

Alameda-based Avigen said Wednesday that the firm has hired two investment banks to evaluate offers for the firm and its assets. According to the firm, RBC Capital Markets and Pacific Growth Equities LLC will oversee review of merger and ac...

Alameda-based Singulex said this week that it has raised $19M in a venture financing round, led by JAFCO Co., Ltd. The firm said that the round also included prior investors Orbimed Advisors and Fisk Ventures. Hironori Hozoji of JAFCO Life ...

Brisbane, California-based BiPar Sciences, a biopharmaceuticals firm focused on treatments for breast cancer, said Tuesday morning that it has raised $20M in a combination of equity and venture debt. The firm said the funding came from its ...

Menlo Park-based Alter-G, which develops medical devices for the rehabilitation market, said Tuesday that it has raised $8M in a Series B funding round. The funding came from Versant Ventures. The firm said that Ross Jaffe of Versant Ventur...

Menlo Park-based Acclarent, which develops medical devices for treating ear, nose, and throat conditions, said today that it has raised $26M in a financing round. The round came from Johnson & Johnson Development Corporation, along with exi...

Redwood City-based Gene Security Network, which develops molecular diagnostics technology to enhance genetic testing, said Wednesday that it has closed on a $6M Series B funding round. The new funding came from current investors Claremont C...

Palo Alto-based Anacor Pharmaceuticals, a developer of small molecule drugs focused on treating fungal, bacterial, and inflammatory diseases, said Tuesday that it has scored another $50M in a preferred stock financing. The funding came from...

South San Francisco- and Cambridge-based venture capital firm Clarus Ventures, LLC, said this morning that it has named two new partners. The firm said that it has promoted Emmett Cunningham to Partner and Scott Requadt as Transactional Par...

South San Francisco-based KaloBios Pharmaceuticals disclosed Monday that the biotech firm has raised $12M in a second close of its Series D venture funding. According to the firm, the additional capital came from Baxter International Inc. T...

San Francisco- and Boston-based venture firm SV Life Sciences said Thursday that it has named a new Venture Partner at the firm. The venture capital firm, which makes investments in biotechnology & pharmaceuticals, medical devices & instrum...

San Francisco-based DecisionView, a supplier of software used for managing clinical trials, announced Tuesday that it has closed a Series D investment. The funding round came from Granite Ventures, Adobe Ventures, and Aeris Capital. Amount ...

Mountain View-based Broncus Technologies, which is developing medical devices for treating emphysema, said Thursday that it has raised $38M in a Series G Funding. The round was led by Ares Life Sciences AG, which invested $25M in the firm. ...

Hayward-based Arete Therapeutics, which is a biotechnology firm focused on soluble epoxide hydrolase (s-EH) inhibitors, has added $16.7M in a Series A tranche financing. According to Arete, the tranche was led by Frazier Healthcare Ventures...

Fremont-based Panomics, a developer of genetic assay products, has been acquired by Santa Clara-based Affymetrix, Affymetrix said Tuesday. Affymetrix said it will pay approximately $73M in cash for Panomics. Panomics develops scientific ins...

San Jose-based DFine, a developer of medical devices for treating vertebral compression fractures, said Tuesday that it has raised $30M in a Series D investment. The new round was led by BBT Fund LP and Highland Capital Management and also ...

Cupertino-based BioImagene, a developer of digital pathology products, said Thursday that it has added Siemens Venture Capital as a new investor in the firm. BioImagene said that the funding follows the recently close of a $26M Series D fin...

Burlingame-based APT Pharmaceuticals, which is developing treatments for serious lung diseases, said Tuesday that it has raised $32.3M in a Series B funding. The round was led by Three Arch Partners, and also included new investors InterWes...

Amplyx Pharmaceuticals, a drug development firm developing small molecule drugs, has raised a Series A funding round, worth roughly $700K. The funding came from the Tech Coast Angels and life Science Angels. According to the Tech Coast Ange...